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SUMMARY 
The thesis aimed to develop and characterize a novel detection approach, which we 
termed aptaPCR exploiting nucleic acid aptamers as combined recognition and reporter 
biocomponents for the ultrasensitive detection of analytes.  
Nucleic acid aptamers are synthetic ligands selected from vast combinatorial 
libraries through a process referred to as SELEX – Systematic Evolution of Ligand By 
Exponential Enrichment. As compared to other natural and synthetic receptor, aptamers 
possess unique chemical and biochemical characteristics, such as: a well known 
chemistry, remarkable stability, an ability to be selected against virtually any target 
even in non-physiological conditions. 
Exploiting the unique characteristics of aptamers, we aimed: I) To combine the 
specificity of a generic aptamer with the sensitivity of nucleic acid amplification for 
ultrasensitive detection (aptaPCR) II) To apply the developed aptaPCR to the functional 
detection of proteins, without affecting their physical proprieties using stimuli-
responsive aptamer referred to as caged aptamers III) To select a DNA aptamer against 
the food allergen gluten to demonstrate the functionality of the aptamer using the 
developed aptaPCR method. 
Specifically outlining the work achieved in this PhD thesis, the work is organized 
into individual chapters. 
Chapter I: Statement of the objectives and introduction to the state of the art. 
Chapter II: A real-time apta-PCR for the ultrasensitive detection of thrombin is 
reported, where the thrombin aptamer acts not only as a biomolecular recognition 
element, but also as a reported molecule for amplification via real-time PCR. Aptamers 
can be easily converted to a reporter agent for detection by real-time PCR, simply via 
flanking of the aptamer’s recognition moiety with primer sequences. Here, we use a 
sandwich format, where two existing thrombin binding aptamers with distinct binding 
epitopes were used to capture and detect thrombin in a streptavidin-coated microtiter 
plate. The amount of thrombin was calculated from real-time PCR analysis of the eluted 
captured reporter aptamer. The technique can also be used for aptamer–antibody 
sandwiches, or simply with single aptamers. A greater than 20 000-fold increase in 
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sensitivity was achieved, highlighting the potential of this approach for the detection of 
very low levels of target analytes. The use of the aptamer itself as the reporter molecule 
eliminates the necessity of laborious enzyme/DNA labelling, facilitating a significantly 
more straightforward assay with a vastly enhanced sensitivity, and is a technique 
generally applicable to all aptamers. 
Chapter III: While many diagnostic assay platforms enable the measurement of 
analytes with high sensitivity, most of them result in a disruption of the analyte’s native 
structure and, thus, in loss of function. Consequently, the analyte can be used neither for 
further analytical assessment nor functional analysis. Herein we report the use of “caged 
aptamers” as templates during apta-PCR analysis of targets. “Caged aptamers” refer to 
variants that bear one or more photolabile groups at strategic positions. The activity of 
caged aptamers can thus be turned on or off by light irradiation. The latter allows the 
mild elution of target-bound aptamers while the target’s native structure and function 
remain intact. We demonstrate that this approach allows the quantitative analysis 
functional assessment of analytes. Since caged aptamers can be generated emanating 
from virtually every available aptamer, the described approach can be generalized and 
adopted to any target–aptamer pair and, thus, have a broad applicability in proteomics 
and clinical diagnostics. 
Chapter IV: Celiac disease (CD) is an immune mediated enteropathy triggered by 
ingestion of gluten. So far, the only possible treatment is a lifelong gluten-free diet, 
which implies the need for detection methods of gluten in food. Herein we describe the 
selection of the first DNA anti-gliadin aptamer reported to date, and its use for the 
detection of gliadin in foodstuff. The aptamer selection was achieved by using the 
Systematic Evolution of Ligand by EXponential enrichment (SELEX) process, which 
permitted the screening of a vast library of a synthetic single stranded DNA library 
(1013 members) through the repetition of different rounds of amplification and selection. 
After eight rounds of selection the enriched library was cloned and sequenced, 
identifying a high conserved sequence. This sequence was characterized for its 
specificity and was used to set in competitive aptaPCR assay for the detection of 
gliadin. Here different concentrations of the analytes free in solution compete for the 
selected aptamer with a standard concentration of the target adsorbed on a microtiter 
plate. Upon its elution from the plate, the aptamer served as template for subsequent 
qPCR and quantification. 
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Chapter V: Overall conclusions.  
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I.I | A NOVEL ULTRASENSITIVE DETECTION ASSAY 
The constant pursuit for a higher analytical sensitivity is reflective of the raising 
needs of our society. Nowadays, monitoring of health, foods, drinks, pollution and even 
security at airport relies on the detection of molecular indicators. In analysis, sensitivity 
is defined by IUPAC as “the slope of the calibration curve”1, i.e. the correlation 
between analyte concentration and response signal2.  
Immunoassays, first described in the late 1950s, rely on the formation of specific 
antibody-analyte complexes. The first assays used radioactive label receptors to 
generate detectable output signal coming from the sandwich type complexes formed 
with surface immobilized and reporter antibodies “sandwiching” the capture antigen3. 
About ten years later, the undesirable radioactive label was replaced by the introduction 
of a novel approach named Enzyme Linked ImmunoSorbent Assay –ELISA4, 5. Here, 
the complex formation is monitored thanks to the fluorogenic-or chromogenic- activity 
of an enzyme conjugated to the reporter antibody. When a single analyte molecule 
recruits an enzyme -as a part of the antibody-antigen complex-, it will generate a 
multitude of reporter molecules, which produce a detectable signal measured using 
fluorescence -or UV/Vis- spectroscopy. The result is an assay that is safe and easy to 
perform, where the sensitivity is comparable to that attained using radioactivity. 
Nonetheless, such sensitivity is still far from the ultralow detection levels sought. 
The detection of such levels became possible in the middle of the 80s, when K. 
Mullis first described a breakthrough technique for the amplification of nucleic acids: 
the polymerase chain reaction (PCR)6. In PCR a thermophile enzyme is used facilitating 
an exponential rather than a linear amplification and thus allowing detection of a few 
nucleic acid molecules. Exploiting the advantages of PCR in the early 1990s Cantor’s 
group modified the ELISA format to Immuno-PCR7 approach, where the reporter 
enzyme is replaced by a DNA tag, which serves as a template for PCR, enhancing the 
sensitivity of a common immunoassay by up to 100000-fold 8-11. 
Whilst Immuno-PCR offers great sensitivity, the technique does suffer from some 
important drawbacks, such as difficulties in labelling the antibody with nucleic acids 
and, furthermore, this linkage, either directly to antibodies or via biotin-streptavidin 
linker bridges is prone to a lack of precision often resulting in uneven numbers of oligos 
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per antibody, resulting in high rates of error and affecting sensitivity 12, 13. Additionally, 
following the immunorecognition step, the DNA needs to be separated from the 
antibody for subsequent amplification. 
Taking advantage of the aforementioned considerations, we wished to explore the 
opportunity of further improvements in the field of ultrasensitive detection, pursuing an 
user-friendly, inexpensive but ultrasensitive assay; replacing the cumbersome antibody 
conjugated to a DNA tag with a DNA aptamer. Indeed, aptamers do not require to be 
conjugated to a label as they can inherently act both as detecting and reporting 
molecule, overcoming the problems with immuno-PCR. Once we had demonstrated the 
proof of concept of “aptaPCR”, we applied the approach to the functional detection of a 
food allergen using an aptamer selected against gliadin. 
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I.II | APTAMERS 
I.II.I. IN VITRO EVOLUTION 
Aptamers are artificial receptors that bind to their cognate target with high affinity 
and specificity and are selected through a Darwinian-like evolution method. Aptamers 
are generally single stranded nucleic acid molecules such as RNA14, 15, single stranded 
DNA (ssDNA)16, 17 or their unnatural analogues18, 19; but dsDNA20, 21 and peptide 
aptamers22, 23 have also been described. 
First described in 1990, aptamers came from advances in medicinal chemistry and 
molecular biology achieved over the previous 30 years. In the 1960s along with 
extraordinary progress in the chemical synthesis of artificial nucleic acids24 and the 
understanding of the genetic code25, 26, there was an increasing awareness of the role of 
nucleic acids. Molecular biologists understood that oligonucleotide could represent 
something more than mere storage information (or structural) biopolymer, playing a 
crucial role in the evolutionary path, from macromolecule to life27-29. Indeed, since 
nucleic acids bear the blueprint for their own synthesis, they can be selected for their 
inherent attributes through Darwinian evolution, or as Leslie Orgel wrote 
“...polynucleotide chains could make primitive selection among organic molecules (…) 
by forming stereospecific complexes stabilized by hydrogen-bonding”29.  
Experimentally, in the mid 1960s Spiegelman and co-workers provided the first 
evidence of the evolution of nucleic acids. The group reported the “extracellular” 
evolution of RNA molecules, as a result of the amplification of bacteriophage genomes 
through a species-specific RNA replicase30. They selected short RNA molecules - 
characterized by a high amplification rate- starting from genomic RNA through serial 
transfer experiments - where the product of one replication was used as a template for 
subsequent replication. 
Spiegelman’s work probably represented the main breakthrough towards the 
discovery of aptamers, as Darwinian evolution was finally elevated to a chemical 
process31. Nonetheless, the Spiegelman’s “extracellular” evolution presented a 
fundamental bias: the replicase used for the replication was extremely specific, so that 
the process could not produce other than high affinity ligands for replicase itself. In the 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
 
Alessandro Pinto | PhD Dissertation  
5 
middle of the 1980s, the introduction of the PCR – which allows the replication of all 
oligonucleotides - overcomes such bias. Updating the Spiegelman approach using PCR, 
in March 1990 Robertson and Joyce published the direct selection of a RNA ribozyme 
that cleaves ssDNA32. Here, after incubation with ssDNA to cleave, the collection of 
Thetrahymena ribozyme’s derivatives was amplified through RT-PCR, and the two 
steps were repeated. Similar to Spiegelman, also in this case selection occurred at the 
amplification stage where the cleavage, mediated by the RNA, caused the ligation of 
part of the ssDNA to the RNA itself, creating a new region necessary for the successful 
annealing of a primer.  
In August 1990, the report from Robertson and Joyce was followed by the 
publication of two more articles, independently reporting examples of in vitro evolution 
of nucleic acids. Remarkably, these new reports described a process further modified 
and  -more interesting- used to screen vast combinatorial RNA libraries for the 
identification of target-specific RNA ligands.  
 
Figure I-1. BREAKTHROUGHS FROM DARWIN’S “ON THE ORIGIN OF SPECIES” PUBLICATION TOWARDS THE IN VITRO 
SELECTION OF APTAMERS. 
Tuerk and Gold from the University of Colorado described the selection of RNA 
molecules that bind to the bacteriophage T4 DNA polymerase33. The two scientists 
created a library of about 65536 different RNA molecules, based on the natural T4 
polymerase target – a hairpin structure- randomizing eight positions of a template 
contains regions for the amplification, and used it in a novel in vitro evolution process, 
referred as SELEX - Systematic Evolution of Ligands by Exponetial enrichment. Unlike 
the process used by Joyce and Spiegelman, in SELEX the selection occurs before 
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amplification, through the physical separation of the bound sequences from the un-
bound ones. Not surprisingly, thanks to its simplicity, the SELEX process patented by 
its creator more than 20 years ago is still the main strategy for the identification of 
artificial nucleic acid ligands. 
Using a similar approach – just about twenty days after the publication of Tuerk and 
Gold- Ellington and Szostak from the Massachusetts General Hospital reported the 
selection of RNA molecules that bind to small organic dyes 34. In this case no natural 
RNA ligands for the target were known, furthermore the selection started from a 
combinatorial library of RNA molecules containing a random region of hundred random 
nucleotides flanked by regions for amplification, representing a pool of more than 1013 
different molecules. Using six different dyes immobilized in agarose columns as 
potential targets, the duo isolated individual RNA sequences that specifically bound to 
some of the organic dyes used. The group coined the term aptamer from the Latin word 
aptus means to fit. 
 
Figure I-2 APTAMERS IN LITERATURE, FROM 1991 TO DECEMBER 2011. Results obtained seeking the word “aptamer” 
in title, abstract and key words of articles indexed by Scopus. 
Since their first appearance, aptamers have garnered constantly increasing attention, 
reflected in the growing number of publications 35- Table 1, which encompass the 
development of diagnostic reagents and therapeutic lead compounds. 
Aptamers possess unique chemical and biochemical characteristics, such as a very 
well known chemistry, remarkable stability and attractive pharmacokinetic and 
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pharmacodynamics features; moreover aptamers can be selected against virtually any 
target and in non-physiological condition, as no animal host is required. 
 
I.II.II. OVERVIEW OF THE SELECTION PROCESS 
The SELEX procedure developed by Tuerk and Gold is routinely employed in the 
selection of aptamers. The process starts with the synthesis of a ssDNA library 
containing a random region flanked at both ends by fixed sequences -necessary for 
annealing of the primers for amplification. Upon amplification of the pool, RNAs or 
ssDNAs are generated (conditioning), and the single stranded nucleic acid pool is 
incubated with the desired target and subsequently the bound nucleic acids are 
recovered (partitioning). Finally the enriched pool is amplified to start a new round of 
selection. Typically, a SELEX starts with 1013 - 1015 different molecules and requires 8-
15 rounds to obtain a pool of aptamer candidates with a high binding affinity for the 
target. The number of rounds depends on different parameters, such as design of the 
oligonucleotide library, type of target, oligonucleotide to target ratio, selection 
conditions, and the efficiency of the partitioning methodology.  
To improve the possibilities of selecting high affinity aptamers, the stringency 
during the selection process can be increased by reducing the target concentration or 
changing the binding and washing conditions 36. Additionally, to reduce the chances of 
evolving non-specific binders, those sequences of the library that bind to the support 
material (e.g. affinity chromatography column, magnetic beads, nitrocellulose filters 
etc.) can be excluded, performing a pre-incubation without the target before each round, 
a process termed as negative selection 37. In a similar manner, to reduce the cross-
reactivity of the selected aptamer, a pre-incubation step in the presence of potentially 
interfering molecules, that are structurally similar to the target, can be carried out in an 
additional step referred to as counter selection 38, 39. 
The evolution of the pool affinity along with the selection process can be monitored, 
and well-timed changes in the procedure can be introduced accordingly. The technique 
most commonly used for monitoring of evolution uses radioactively labelled nucleic 
acids 40-42, but the use of fluorescent labels 43 or  dye-linked aptamer 44 have also been 
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reported as have the use of capillary electrophoresis, affinity chromatography and 
surface plasma resonance (SPR) 45-48.  
When the enriched library shows no more affinity enhancement, the pool is cloned 
and sequenced. The identification of common sequences as well as homologous regions 
in the pool and the comparative analysis of the sequences are used to determine the 
consensus motif: the region playing the main role in the specific binding of the target. 
The selected aptamers are subsequently characterized by means of binding studies to 
determine both their specificity and affinity. For this purpose, techniques like SPR, 
enzyme linked oligonucleotide assays (ELONA) and fluorescent or radioactive binding 
assays are often used.  
Despite the great potential, the rate of success of SELEX has been reported to be 
~50%49.  To improve the likelihood of success, during the last twenty years the patented 
Gold’s procedure has been modified: instead of sepharose or agarose columns 50-53, 
magnetic beads have been used as solid support for the target immobilization or 
alternatively ultrafiltration38, 54-56 without target immobilization can be used. As 
alternatives, the use of flow cytometry 57-59, Surface Plasmon Resonance (SPR)46, 
Atomic force microscopy (AFM)60, electrophoretic separation 61-64 and centrifugation 65, 
66 have also been described.  
I.II.III. APTAMER FEATURES 
From 1990, nucleic acid aptamers binding hundreds of different targets have been 
reported – from small inorganic molecules to complex targets like target mixtures or 
whole cells (Table 2). Aptamers – ranging in size from 6 to 40 KDa - bind to their 
cognate target through the formation of specific complexes stabilized by non-covalent 
interactions: which are a combination of Van der Waals forces, hydrogen bonds and 
electrostatic interactions. As reviewed by Patel et al., the binding triggers an adaptive 
folding in which the target promotes and stabilizes the secondary and tertiary structures 
of aptamers67, 68. The dynamic conformations of free aptamers69 – consisting of labile 
knots, loops and stems, become  stable architectures in the aptamer-target complexes 
where non-canonical base-pairing  (Hoogsteen pairing to form triplex, Wobble base 
pairing, g-quadruplex structure etc.) along with the inter molecular interactions create 
“(…) unique ligand-binding pockets”70. 
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As a result, aptamers bind to their cognate with high affinity as well as specificity. 
Remarkably, the affinity achieved by aptamers is similar - sometimes even better- than 
that achieved by antibodies71. In terms of dissociation constant (Kd), the affinity of 
aptamers range from sub-pM to µM, with low nM Kd being common for protein targets. 
The specificity of aptamers is not less appreciable than their affinity. A classic 
example of this being the anti-theophylline aptamer72, which is able to discriminate 
between theophylline and caffeine: two molecules that only differ structurally by a 
methyl group on the imidazole ring and the affinity of the selected aptamer for 
theophylline is about 11000 times higher than its affinity for caffeine. Remarkably, 
aptamers are also capable of enantiomer discrimination as described by Geiger et al. 
who successfully selected an anti- L-arginine aptamer that showed an affinity for the L-
arginine 12000 times higher than its affinity for the D- form of the same 
aminoacid73.Furthermore aptamers have been selected that distinguish between related 
macromolecules (e.g. ADP from ATP74) or protein family members- such as the 
Keratinocyte growth factor and other fibroblast growth factors75. 
Asides from their noteworthy affinity and specificity, aptamers are exceptionally 
stable, and may undergo denaturation, but the process is totally reversible within 
minutes. Hence, temperature changes or long-term storage do not affect their 
functionality.  
Natural nucleic acids aptamers –RNA or DNA - are generally sensitive to the 
hydrolytic action of nucleases universally present in biological samples. RNA aptamers 
are slightly less stable as the hydroxyl group at 2’-position on the ribose promotes 
phosphodiester bond hydrolysis, particularly at high pH or in the presence of metal ions. 
To overcome these shortcomings chemical modification can be used. Indeed, compared 
to other receptors, aptamers can be easily modified by the introduction of new 
functional groups, which can confer higher stability and nuclease resistance, bring novel 
physical/chemical proprieties and even improving the overall affinity for the target. 
New functional groups can be introduced a priori -within the SELEX process- using 
modified nucleic acid libraries, or a posteriori modifying a selected DNA/RNA through 
chemical synthesis 86. While the first approach relies on the compatibility of the 
modification adopted with the enzymatic amplification necessary for selection; the latter 
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approach is streamlined by detailed knowledge of the structure of both the aptamer and 








DNA 6-19 nM 
76 
Zinc  65 Metal ion RNA 100-400 µM 
77 
Cocaine  303 Drug  DNA 0.4-10 µM 
78 
Tetracycline  444 Antibiotic DNA 63-483 nM 
79 
ATP 507 Coenzyme RNA 450 nM 
80 
Sulforhodamine B 558 Organic dye DNA 190 ± 20 nM 
81 


















Burkitt's lymphoma cell - Whole Cell DNA 49.6±5.5 nM 
85 
Table I-1 EXAMPLES OF APTAMERS DESCRIBED IN LITERATURE. 
To improve the stability of aptamers, modified RNA pools are commonly 
employed: in particular by using 2′-amino or 2′-fluoropyrimidine derivatives both of 
which are suitable for enzymatic amplification 75, 87-91. The use of phosphorothioate 
modified RNA92 and DNA93-95 aptamers have also been described. Aiming to improve 
both the affinity and the specificity of the aptamers, RNA pools containing 5-
iodouridine instead of uridine, and DNA pools containing 5-bromo-2´-deoxyuridine 
instead of thymine have been used in an updated SELEX protocol named photo-
SELEX. As an example of addition of functional groups a priori, in an attempt to 
increase the chemical diversity of the natural nucleic acid, an anti-thrombin modified 
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DNA aptamer was obtained from a library of modified DNA containing 5-
pentinyldeoxyuridine instead of thymidine96. Likewise, an ATP-binding aptamer was 
selected from a cationic-modified DNA pool containing 5-amino-propynyl 
deoxyuridine97, and a library of modified DNA containing 5-(2-(6-aminohexylamino)-
2-oxoethyldeoxyuridine was successfully employed in the selection of a modified DNA 
aptamer specific to the thalidomide derivative98. 
Post-selection modifications are extensively used. Indeed, aptamers are commonly 
conjugated to reporter moieties 99. Aptamers can be easily linked to biotin, thiols, 
amines, phosphates, and cholesterol to protect them from exonuclease100-102 and to allow 
their immobilization and conjugation to enzymes103 or nanoparticles104, 105. 
Improving the overall stability of a previously identified HIV-1 reverse transcriptase 
(RT) aptamer106 and vascular endothelial growth factor (VEGF) binding aptamer, Green 
et al. studied the effect of appending methoxyl groups to the 2’-position of the ribose. 
Locked Nucleic acids (LNA) – which contains a 2’-O,4’-C-methylene bridge - were 
used to modify the anti- HIV-1 trans-activation responsive (TAR) RNA aptamer 107 and 
the avidin-binding DNA aptamer108. 
Chimeras formed by the conjugation of the aptamer with other functional 
macromolecules have been described. For example the VEGF aptamer was linked to 
distearyl glycerol through phosphoramidite chemistry, for the subsequent anchoring of 
the VEGF ligands in liposomes109. As a result this lipid-modified aptamer exhibited a 
dramatic improvement in its anti-VEGF activity. Constructing a chimera by conjugating 
a small tetrapeptide competitor (N-methoxysuccinyl–Ala–Ala–Pro–Val 
cloromethylketone) to the 3′-sulfhydryl modified end of the aptamer, Lin et al. were 
able to improve the inhibitory function of a previously developed human neutrophil 
elastase binding aptamer110. Furthermore, chimeras obtained by the fusion of two 
different aptamers have been described: either to create bi-functional molecules 111, 112 
or to improve the overall affinity for the target113.  
Using analogues of natural nucleotides that bear photolabile groups at strategic 
positions, known as “cages”, the thrombin binding aptamer114, 115 as well as the 
cytohesin binding aptamer116 were modified. As a result the activity of such variants - 
referred to as caged aptamer- can be turned on or off by light irradiation. 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
Chapter I| Introduction 
12 
To summarize, aptamers can be tailored for many potential applications, in ways 
unavailable for other receptor molecule (e.g. antibody). Other advantages include the 
lack of batch-to-batch variation, their small size and compatibility with platform 
developed for genomics (e.g. DNA microarray) and finally the production cost of 
aptamers is about the 90% less than that of an antibody117.  
I.II.IV. APTAMERS IN ANALYSIS 
Affinity	  Assay	  
Since their appearance, aptamers have shown great promise as biocomponents for 
analysis, not only due to their high affinity and specificity, but also due to their 
increased stability, flexibility and versatility as compared to antibodies. Techniques 
involving antibodies or phage displayed antibody fragments are increasingly being 
replaced by aptamers in different configurations, taking advantage of the unique 
properties of aptamers. 
 Ellington was the first to exploit aptamers for the quantification of a specific 
protein in a cell extract using radio-labelled aptamers in a filter binding assay 118. By 
means of previously selected RNA aptamers immobilized on a nitrocellulose filter, βII 
isozyme of rat protein kinase C was quantified with high reproducibility and specificity 
in the presence of rat brain extract. While Ellington was demonstrating the concept, at 
Larry Gold's NeXus Pharmaceutical Inc., Drolet et al. reported the first use of aptamers 
in an enzyme-linked immuno-sorbent assay (ELISA)-like assay, referred to as ELONA 
– Enzyme-Linked Oligo-Nucleotide Assay - or more correctly RLAA – Reporter Linker 
Aptamer Assay. In this first reported RLAA 119 the reporting antibody of a sandwich 
ELISA was substituted by a fluorescein-tagged RNA aptamer to detect the vesicular 
endothelial growth factor (VEGF) in serum. A monoclonal antibody specific for VEGF 
was immobilized and used to capture the target, followed by incubation of a VEGF-
binding fluorescein-labelled RNA aptamer with the detection facilitated by an enzyme-
labelled anti-fluorescein antibody. This cumbersome assay yielded results very similar 
to those obtained in typical ELISA, being able to detect concentrations down to 1 pM 
and without showing any cross-reactivity towards other cytokines.  Although this work 
did not exploit specific properties of aptamers, it did highlight the possibility of 
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aptamers to compete with, and complete the use of, antibodies in bioanalysis, paving the 
way for a new approach for detection. 
Since its conceptualization in 1971, ELISA 120 has been extensively used in 
diagnostics as well as in research, due to the robustness, suitability to automation and 
relative simplicity of the method. Nevertheless, the emerging needs of ever decreasing 
detection limits, necessitates the search for new assays and methodologies - such as 
immuno-PCR - that can meet these demands and keep ELISAs at the cutting edge. As 
such, RLAAs represent a natural development of ELISAs, exploiting the unique 
flexibility of aptamers to achieve reliable and consistent detection of very low levels of 
target molecules, but still using a microtitre plate format. 
In simple formats, aptamers have been exploited in RLAA in much the same way as 
antibodies in ELISA 121. Amongst others, Vivekananda and Keil reported a RLAA 
format that employs aptamers both as capturing and reporting elements 122. Aiming to 
detect an antigen associated with Francisella tularenis japonica - a bacterium that causes 
the infectious endemic disease tularemia, the group selected different DNA aptamers 
against the target to be used in the RLAA, where the reporting oligonucleotide was 
labelled with biotin, recognised in turn by streptavidin-HRP. The results obtained 
demonstrate that in terms of detection, the RLAA sandwich is superior to ELISA, 
lowering the Limit of Detection (LoD) by about 3 times - from 6.9 to 1.7 x 103 
bacteria/mL, whilst also improving the specificity. An exhaustive work regarding the 
different RLAA sandwich formats was accomplished by Baldrich et al., where different 
RLAA and mixed antibody/aptamer formats using the Thrombin Binding Aptamer 
(TBA) were studied, elucidating the critical parameters for optimal aptamer 
performance, highlighting that the conditions for each aptamer assay must be 
individually optimized and unlike ELISA, that no universal optimal operating 
parameters exist 123. The authors went on to detail the first report of an aptamer-based 
displacement assay. Based on the observation that the TBA had a lower affinity for a 
modified form of thrombin than for the native form, microtitre plates were coated with 
the aptamer to retain horse peroxidise (HRP) modified thrombin. Following the addition 
of the native thrombin, HRP-thrombin was displaced, achieving a LoD of below 10 nM. 
Although, displacement assays with antibodies have been a long-time goal, very few 
reports of successful assays have appeared 124-128, and this first report of an aptamer in a 
displacement assay not only highlighted the flexibility of aptamers to different assay 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
Chapter I| Introduction 
14 
formats, but also demonstrated the long-term stability of immobilized aptamers. 
Demonstrating significant advantages of aptamers over their antibody counterparts, 
Cruz-Aguado and Penner also demonstrated the displacement assay is possible with 
other aptamers, obtaining nanomolar detection limits of ochratoxin A (OTA) through a 
displacement assay by means of anti-OTA aptamer and a complementary fluorescein 
labelled oligo with fluorescent polarization detection 129. The group of O' Sullivan (oral 
communication and manuscript in preparation) has also demonstrated the format with 
an in house selected avidin aptamer, where SPR has been used to evaluate the Kd of the 
aptamer for avidin, streptavidin and streptavidin-HRP, observing an one order of 
magnitude lower Kd for the latter two. The group exploited this in a displacement assay 
where immobilized avidin aptamer was incubated with the streptavidin-HRP followed 
by a 15-minute incubation with the target avidin, achieving nanomolar detection limits.  
Magnetic beads (Mb) have also been exploited as supports for RLAA formats, using 
either immobilized or labelled aptamers as capture or detection reagents. Bruno and 
Kiel used magnetic beads to develop a RLAA sandwich able to detect non-pathogenic 
Sterne strain Bacillus anthracis spores 130, cholera whole toxin and Staphylococcal 
enterotoxin B at nanogram to low picogram levels 131. The approach used relies on a 
selected pool of DNA aptamer immobilized on tosyl-activated magnetic beads used to 
capture the analyte in solution. The detection was accomplished by exposing the beads 
to a second biotinylated aptamer pool followed by addition of either streptavidin-
conjugated ruthenium trisbypyridine or avidin-HRP conjugate. Rye and Nustad 
developed a hybrid immuno-beads assay based on 5’-biotinylated DNA thrombin 
aptamer and anti-thrombin antibody 132. In this case, sheep anti-mouse IgG was 
conjugated to magnetic beads and used to bind the IgG anti-thrombin monoclonal 
antibody. The modified beads were then exposed to a pre-incubated mixture of 
thrombin and biotinylated thrombin aptamer. Finally, europium (Eu)-labelled 
streptavidin was added for detection. The results revealed the TBA could bind the target 
under both stringent conditions and physiological concentrations, again highlighting the 
enhanced flexibility of aptamers for analytical applications. 
Demonstrating the impressive robustness of their use, aptamers have been tested in 
depth in many affinity assay formats: besides RLAAs, aptamers have been exploited in 
flow cytometry, affinity chromatography and capillary electrophoresis, amongst others.  
In flow cytometry analysis, labelled aptamers were used for detecting (and isolating) 
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analytes immobilized on beads 99, as well as biomarkers expressed on cell surfaces 133-
135. Fluorescent labelled  aptamers have also been used in capillary electrophoresis to 
detect IgE in buffer and serum samples 136, 137 or the reverse transcriptase of the Human 
Immunodeficiency Virus type 1 (HIV-1) 138, 139. Furthermore, the high affinity, stability 
and the small size of the aptamers have facilitated their use in affinity chromatography.  
Aptamers immobilized in the stationary phase were demonstrated to obtain a very high 
selectivity in the retention of targets, as demonstrated by the efficient separation of 
arginine enantiomers 73, the purification of fusion protein from cell lysate 140 or the 
separation of adenosine at different phosphorylation levels 141.  
Aptasensors	  
According to the IUPAC definition 142 “A biosensor is a self-contained integrated 
device, which is capable of providing specific quantitative or semi-quantitative 
analytical information using a biological recognition element (biochemical receptor) 
which is retained in direct spatial contact with an electrochemical transduction 
element.”  The analytical power of biosensors relies on the molecular recognition 
element used. Aptamers offer many advantages as biocomponents, such as their size, 
ease of modification, facile immobilization compatible with developed microarray 
technologies, as well as flexible detection formats. Furthermore, aptamers offer unique 
chemical and physical proprieties for the construction of re-usable biosensors. 
Optical aptasensors  
One of the first examples of aptasensors was reported by Kleinjung et al. 143 for the 
detection of L-adenosine through the cognate RNA aptamer immobilized over optical 
fibres via a biotin-streptavidin bridge, where total internal reflection fluorescence from 
the fluorescein isothiocyanate (FITC) labelled L-adenosine in competition with the 
unlabelled L- and D- enantiomers was used.  In parallel, Ellington's group designed an 
aptasensor in which a FITC modified thrombin binding aptamer (TBA) was used as a 
signalling probe for thrombin detection 144, monitoring the evanescent-wave-induced 
fluorescence anisotropy of a microscope slide-immobilized aptamer, detecting 
subnanomolar levels of analyte in a few picoliters in less than five minutes. Using the 
conformational switch properties of aptamers, Jahaveri et al. exploited the unique 
properties of aptamers to achieve detection introducing fluorescent labels on the 
aptamer at positions where the fluorescent moiety enhanced the intensity of the 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
Chapter I| Introduction 
16 
emission upon target binding 145. The authors described the successful modification of 
both RNA and DNA ATP binding aptamers by using a moiety of acridine 
phosphoramidite, thus positioning the fluorophore outwards following target binding.  
Using the same principle Katilius et al. developed DNA aptamer detection systems for 
thrombin, IgE and platelet-derived growth factor using fluorescent nucleotide analogues 
146. The advantage of this last approach is that little or no decrease in binding affinity is 
expected due to the introduction of the fluorescent moiety, but it is still critical to 
correctly identify the optimal position to introduce the reporter moiety.  
The use of a reporter pair rather than one single molecule has been intensively 
investigated to detect the conformational changes induced by the target recognition. The 
first report of this type of strategy was from Tyagi and Kramer who detailed a nucleic 
acid molecular beacon for the detection of specific nucleic acid sequences 147. Here 
single stranded nucleic acid probes form a characteristic hairpin structure with each 
terminal labelled with a fluorophore and a quencher, respectively, which, in close 
proximity result in fluorescent quenching. Following hybridization with its 
complementary sequences, the hairpin structure undergoes a spontaneous 
conformational change, breaking apart the hairpin structure, and thus generating the 
signal.  Due to the nucleic acid nature of aptamers, they can easily be formatted into a 
molecular beacon structure, again demonstrating their superior flexibility to alternate 
assay formats for analytical applications, as compared with antibodies. 
 Anti-cocaine 78 and anti-PDGF 148 aptamers were engineered to form an aptabeacon 
involving the 3’- and 5’- ends when bound to the analyte. Using a fluorophore at one 
extremity and a quencher on the opposite one, the binding produced a measurable 
'switch-off' of the signal. The anti-thrombin aptamer (TBA) was used in a 'off-on' 
mechanism 149, where the original DNA aptamer was appended with a sequence to form 
a hairpin structure that was destabilized by target binding, which inherently promoted 
the formation of the particular G-quadruplex structure of the TBA thus distancing the 
quencher from fluorophore, with a concomitant increase in fluorescence signal.  A 
similar approach was used by Tang et al. who modified the aptamer with a 
polyethyleneglycol (PEG) spacer followed by a short antisense oligonucleotide 
modified with a quencher in the 3’-terminus 150, demonstrating the viability of the 
method with TBA and the anti-ATP aptamer, achieving 90% of signal intensity in just 
five seconds. 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
 
Alessandro Pinto | PhD Dissertation  
17 
Nutiu and Li have exploited the intermolecular displacement of an oligonucleotide 
from a complementary sequence. The authors used a fluorophore-labeled DNA aptamer 
and an antisense small oligonucleotide conjugated to a quenching moiety 151, and was 
facilitated by the signal generated due to displacement of the antisense oligonucleotide, 
where an aptamer/antisense-oligonucleotide duplex was used with the antisense 
sequence being released following recognition of the target, and the fluorophore thus 
able to  generate signal.  Similarly, Li and Ho described the detection of ATP using a 
switch-off mechanism taking advantage of a duplex formed by the anti-ATP aptamer 
and the antisense oligonucleotide labelled at the extremities with a fluorophore-
quenching pair. The signal is quenched when the analyte promotes the displacement of 
the antisense strand, which is free to form a beacon structure152.   Avoiding direct 
conjugation of the aptamer with reporter moieties, a chimera comprised of two active 
aptamers fused together, has been detailed by Stojanovic and Kolpashchilov. The 
authors used ATP, theophylline or flavin mononucleotide (FMN) binding aptamers 
merged with the anti-malachite green aptamer, forming a two domain chimera 153. 
When the analyte domain was bound to the target, an allosteric activation occurs 
allowing the binding of the malachite green to the second domain, promoting the 
enhancement of the dye fluorescence. 
As well as organic dyes, metal complexes 154 and water-soluble cationic polymers 
have been used as reporters 155. An easy and universally applicable set up was described 
by Ho and Leclerc to detect thrombin using polythiophene, a cationic water soluble 
polymer that binds to the negatively charged backbone of the oligonucleotide 156. Upon 
binding to thrombin the TBA undergoes a conformational change, inducing the polymer 
to wrap the folded G-quadruplex structure rather than form a planar and highly 
conjugated structure with unfolded ssDNA, producing a colorimetric signal used to 
detect as low as 2 × 10-15 mol of human thrombin. 
Gold nanoparticle (AuNPs) have also been used as reporters, exploiting their unique 
property to change color upon aggregation 157. This property has been used by Mirkin et 
al. to develop oligonucleotide-modified AuNP probes 158, where hybridization with the 
promoted nanoparticle aggregation inducing a color change. Using a similar principle 
Liu and Lu designed ATP and cocaine biosensors, by means of two oligonucleotides 
each conjugated to a AuNP and complementary to two different regions of the anti-ATP 
aptamer; in the absence of analyte a duplex is formed, crosslinking the nanoparticle and 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
Chapter I| Introduction 
18 
resulting in aggregation. However, when the aptamer folds up, binding the analyte, the 
duplex is broken causing disaggregation 159. In a similar approach, Zhao et al. used an 
anti-ATP aptamer, which was hybridized to a short oligo attached to a AuNP, where the 
presence of the duplex prevented aggregation due to the repulsion of the negative 
charges of the aptamer backbone, with duplex destabilization due to the presence of the 
target resulting in aggregation 160.  
Quantum dot nanoparticles (QDs), nanocrystals offering greater photostability, 
longer fluorescence lifetime and sharper emission bands than traditional dyes, have also 
been used as reporters. Levy et al.  reported on a Fluorescence Resonance Energy 
Transfer (FRET)-based aptasensor where a QD nanoparticle was conjugated to TBA 161, 
which formed a duplex with an antisense oligonucleotide labeled with quencher, 
dampening the QD signal. Following addition of thrombin the aptamer underwent a 
conformational change, releasing the complementary antisense and the QD signal was 
restored.  
Surface plasmon resonance (SPR) has also been used to monitor aptamer-target 
binding, for example for detection of the retinol-binding protein 4 (RBP4) in serum 162, 
as well as the detection of the 2’-5’ oligoadenylate synthase 144 and others 163-167. In a 
further report exploiting surface plasmon phenomena, the use of nanoparticle plasmon 
resonance (NPPR) has also been recently reported, where Hernandez et al. detailed an 
aptananosensor comprised of a noble metal nanoparticle coated with an anti-avidin 
aptamer used to detect as low as 20nM avidin.  168 
Mass aptasensors  
Piezoelectric transduction via a quartz crystal microbalance (QCM) has been used to 
detect thrombin and the HIV-1 Tat protein with low detection limits 169. In addition, the 
catalytic activity of immobilized aptazymes has been monitored in real time looking at 
the changes in QCM frequency, where Knudsen et al. adapted the catalytic ligation 
activity of the anti-HIV-1 Rev peptide aptazyme to detect the HIV-1 Rev peptide as 
well as the cleavage activity of the theophylline aptazyme for the detection of 
theophylline 170.  Another example of mass based aptasensing exploits the use of a 
microcantilever functionalized with aptamers to detect Taq DNA polymerase and the 
hepatitis C virus 171, 172. Furthermore, Schlensong et al. immobilized aptamers on a 
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surface acoustic waves (SAW) device to detect thrombin and HIV-1 Rev peptide 173, 
using the changes in the propagation of the acoustic waves for transduction. 
Electrochemical aptasensors  
The first example of an electrochemical aptasensor was reported by Ikebukuro et al., 
who reported on a sandwich assay to detect thrombin using chronoamperometry 164, 
where the TBA was immobilized via a thiol terminal on a gold electrode to capture the 
target analyte. Following exposure to the analyte, the electrode was exposed to a second 
aptamer against a different epitope of the thrombin and conjugated to pyrrole quinoline 
quinone glucose dehydrogenase (PQQGDH), which generated an electrochemical signal 
using glucose substrate and methoxyphenemethosulfonate mediator, achieving a LoD of 
10nM.   A similar detection limit was obtained by Bang et al. who used a thrombin 
aptabeacon immobilized over the electrode surface with the redox indicator methylene 
blue 174, which was released when the stem loop was opened upon binding with 
thrombin, with a concomitant decrease in electrochemical signal. A similar format was 
reported by Xiao et al. who conjugated the methylene blue moiety directly to an 
extremity of the TBA and attaching this electrochemical aptabeacon to an electrode 
surface, achieving a detection limit of 10 nM LoD and applying the sensor to the 
analysis of thrombin in real serum samples 175. In this case, the authors used the longer 
TBA and in the absence of target the aptabeacon has enough elasticity to contact the 
electrode surface, but upon binding the quadruplex is induced, forming a rigid structure, 
with the MB label located far from the electrode surface in a "switch-off" mechanism. 
In order to achieve a "signal-on" mechanism, Xiao et al. immobilized the TBA aptamer 
on a gold electrode surface via an oligonucleotide linker, and then hybridized the probe 
to an oligonucleotide conjugated at one extremity with the methylene blue. Upon the 
addition of the analyte, the aptamer favoured target binding with the thrombin and 
dehybridized from its' complementary, rendering flexibility to the probe and facilitating 
accessibility of the methylene blue moiety to the electrode surface 176. 
Using an alternative format, where the folding of the TBA into a G-quadruplex 
structure upon the binding with the thrombin was exploited, Radi et al reported an 
electrochemical aptabeacon with a "switch-on" mechanism 177.  The TBA was 
immobilized on a gold electrode via one terminus and ferrocene labelled at the other 
terminus, which, in the absence of the target, was located too far from the electrode 
surface to facilitate electron transfer.  However, the conformational change of the 
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aptamer from a random coil to a G-quadruplex upon target binding brought the 
ferrocene label in close proximity to the gold surface, facilitating electron transfer and 
signal generation with a sub nanomolar detection limit. Further reports of 
electrochemical aptabeacons also exploited the conformational changes undergone by 
the aptamer upon binding, for example the use of methylene blue to monitor the 
formation of the thrombin-TBA complex via chronoamperometry and DPV with a LoD 
of 10 nM 178 as well as the cocaine-cognate aptamer complex via DPV with a LoD of 
500µM 179. 
In another report, an ion-selective field-effect transistor (ISFET) was used to detect 
adenosine in a particular displacement method where no label was required 180. An anti-
adenosine aptamer was immobilized on an electrode surface and hybridized to a shorter 
complementary oligonucleotide, and when adenosine interacted with the aptamer, it 
displaced the shorter oligonucleotide, upon which a change of charge was detected 
achieving a detection limit of a few µM. This detection limit has been improved to a 
few hundred nM by Shen et al. 181 who implemented the system described using 
[Ru(NH3)6]3+,which bound electrostatically to the DNA and when one strand is 
displaced the signal decreases. Similar results have been obtained by Li et al., 182, who 
modified the original set up, by immobilizing a probe complementary to the aptamer on 
the surface and upon addition of the target, the aptamer is liberated from the surface. 
For labeless detection, impedance is one of the most commonly reported 
transduction techniques for electrochemical aptasensors, as detection can be achieved 
simply upon target binding, which changes the impedance. The transduction principle is 
generally based on monitoring the electron-transfer of the electrochemical redox marker 
[Fe(CN)6]4-/3- , whose access to the surface is impeded or enhanced, depending on the 
specific experimental set-up.  Furthermore, as the aptamer is negatively charged and is 
also relatively small as compared to an antibody, one can expect much better sensitivity 
as compared to immunosensors exploiting impedance transduction. Xu and colleagues 
183 first reported the detection of human IgE using Electrochemical  Impedance 
Spectroscopy (EIS) with the cognate aptamer as recognition element, immobilizing the 
aptamer on a gold film electrode via self-assembly, achieving a detection limit of 0.1 
nM.  With an analogous set up, Pan et al. 184 described the detection of a few thousand 
cells/mL of the T-leukemia cell line CCRF-CEM, whilst Radi at al. achieved a detection 
limit of 2 nM thrombin exploiting the 15 mer TBA 185.  Interestingly, using the same 
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approach but replacing the gold electrode with a microfabricated gold thin film, Cai and 
co-workers further decreased the detection limits of thrombin by about 20 times 186 and 
Lee et al. achieved a detection limit of as low as  0.5nM thrombin with pyrolyzed 
carbon film 187. 
Similarly, but using the opposite format, Rodriguez et al. immobilized the 
biotinylated anti-lysozyme aptamer onto a streptavidin-modified indium tin oxide 
surface, exploiting changes of the surface modified charges upon the binding event 
through Faradaic impedance spectroscopy, achieving a detection limit of 10 nM of 
lysozyme 188.  Before the binding event, the negatively charged aptamer on the surface 
creates an electrostatic barrier to the electron transfer of the negatively charged 
ferricyanide couple and this barrier is disrupted when the aptamer binds the positively 
charged cognate target. To enhance the detection limit of a system relying on 
impedance spectroscopy transduction, Xu and co-workers realized an interesting 
approach, where following binding with its cognate aptamer immobilized on a gold 
surface, thrombin was denatured by the addition of the chaotropic agent guanidine 
hydrochloride, resulting in an increase in impedance, achieving a dramatically reduced 
detection limit of just 10fM 189.   
Electrochemical stripping analysis has also been used in aptasensors. Hansen et al. 
190 demonstrated a multi-displacement assay of thrombin and lysozyme labelled with 
quantum dots. Following deposition of thiolated anti-thrombin and anti-lysozyme 
aptamers on gold electrode surfaces, quantum dot labelled thrombin and lysozyme were 
captured by the aptamer and electrochemically stripped at a coated glassy carbon 
electrode. The sensitivity and selectivity of the system was tested with BSA and IgG as 
controls, giving a detection limit of 0.5 pM for thrombin in a signal displacement set-
up. 
Magnetic beads have also been used in combination with electrochemical detection. 
One example cites the use of an anti-lysozyme aptamer labelled with magnetic beads for 
the separation, concentration and detection of lysozyme 191, where the captured protein 
was released from the aptamer for its electrochemical detection by 
chronopotentiometric stripping, achieving a detection limit of 7 nM.  
An indirect square wave voltammetry detection method of aptamer–thrombin 
interaction was reported by Le Foch et al. 192 using the biochemical properties of the 
nucleic acid aptamers. This strategy was based on the specific enzymatic hydrolysis of 
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
Chapter I| Introduction 
22 
single stranded DNA molecules by a nuclease, which did not degrade aptamer attached 
to the target. Thus following enzymatic degradation, thrombin was denatured to release 
the aptamer, which was then hybridized with a DNA capture probe for detection of the 
aptamer achieving a detection limit of 75nM.  
An alternative approach was based on the direct adsorption of thrombin on a 
modified gold electrode surface, with subsequent specific interaction with anti-thrombin 
labelled aptamer 103 detected using chronoamperometry with a detection limit of 3 nM. 
The same group also reported another thrombin aptasensor, based on the thrombin 
based catalysis of the chromogenic substrate, β-Ala–Gly–Arg–p-nitroaniline, producing 
p-nitroaniline, where the rate of p-nitroaniline formation was followed by UV 
adsorption at 405 nm, or electrochemically by the reduction of its nitro group. 
Electrochemical detection was carried out by DPV.   
Finally carbon nanotubes have been exploited as elements in an electrochemical 
aptasensor architecture, where a single-walled carbon nanotube field-effect transistor 
was reported for thrombin sensing 193. The change of the electrical double layer before 
and after interaction with the target was detected and the system achieved a detection 
limit of 10 nM, with a linear range of 0–100 nM. Furthermore, Maehashi et al. 194 
produced label-free protein biosensors based on aptamer-modified carbon nanotube 
field-effect transistors for the real-time detection of IgE, demonstrating a better 
performance than monoclonal antibodies under the same assay conditions.  
In conclusion, a wide range of aptasensor formats has been reported. Exploiting 
formats not possible with immunosensors, impressive detection limits have been 
achieved with facile to use formats, which can be easily applied to mass-producible 
sensors. There has also been a move away from the 'model system' of the thrombin 
binding aptamer, demonstrating the flexibility and potential widespread application of 
aptasensors for highly sensitive, specific and rapid detection of targets, potentially at the 
site of analysis, such as at the point-of-care, for example at a physician's office.  
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I.III | OBJECTIVES AND STRUCTURE OF THE THESIS 
Nucleic acid aptamers are naturally predisposed to an assay format that combines 
the selectivity of the aptamers with the efficiency of nucleic acid amplification 
techniques, producing an impressive signal enhancement with considerably lower 
detection limits. As highlighted before, the concept of integrating the sensitivity of 
nucleic acid amplification with an immunoassay, in a technique known as Immuno-
Polymerase Chain Reaction (Immuno-PCR), precedes the exploitation of aptamers in 
bioanalysis7.  
In the 2002 Friedriksson et al 195 first reported a detection assay exploiting aptamer 
amplification for detecting zeptomoles of the cytokine platelet-derived growth factor 
(PDGF). The approach used, referred as “Proximity Ligation Assay” (PLA), does not 
rely on the immobilization of either the analyte or the probe: two aptamers that bind two 
closely located binding sites are ligated, via a template probe and a ligase enzyme to 
form a unique amplicon to be detected via qPCR. Following this, the same group went 
on to use the technique to detect microbial pathogens 196 and the prostate specific 
membrane agent (PMSA) 197. In a similar format, Yang and Ellington developed a set-
up exploiting the conformation switching of the TBA 198, achieving detection limits in 
the picomolar range. Here taking advantage of the secondary structures assumed by the 
aptamers following target binding, with the conformational change the aptamer 
undergoes upon binding, promoting ligation within a primer region for subsequent real 
time amplification. Later on, this concept was used by the same group to detect PDGF 
in the nanomolar range using rolling cycling amplification, where the conformation-
switching aptamer was circularized upon interaction with its target 199. In an alternative 
approach, Wang et al. 200 described a novel approach where an exonuclease is added to 
a solution containing thrombin and its cognate aptamers, to digest all the 
oligonucleotides free in solution whilst not digesting those that form a complex with the 
analyte. Subsequent amplification of the surviving TBA molecules facilitated a 
detection limit of just a few hundred molecules of thrombin, demonstrating the power of 
this technique for highly sensitive analyte detection.  
Simplifying the PLA approach, avoiding the use of ligases or nucleases, Zhang et al. 
reported on the use of capillary electrophoresis (CE) for the separation of the aptamer-
target complex followed by downstream quantitative PCR, achieving the detection of 
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just 180 molecules of HIV type 1 reverse transcriptase 201. Following this, Fisher et al. 
demonstrated detection of thrombin via Rolling Cycle Amplification (RCA) and real 
time quantitative PCR (qPCR) 202. By means of different concentrations of thrombin 
modified magnetic micro-particles to bind the TBA flanked by two primer regions for 
amplification, the group achieved a 2nM detection limit using the Rolling Cycle 
Amplification (RCA) and as low as a few hundred fM using qPCR.  
In this context, we aimed to integrate detection mediated by aptamer amplification 
within a sandwich assay format. Exploiting two different thrombin binding aptamers 
(TBAs), we detailed a sandwich format where qPCR was used. Here the biotinylated 
TBA for the heparin-binding site was immobilized onto a streptavidin-coated plate, 
which was used to capture the analyte in solution. Subsequently the TBA-thrombin 
complex was exposed to the TBA specific for the fibrinogen-binding site flanked by 
two primer regions, which was finally eluted and detected using qPCR, achieving a 
femtomolar detection limit, as detailed in chapter 2.  
Subsequently we expanded our approach using a caged aptamer as reporter, the 
affinity of which was totally inactivated upon irradiation. Always using the same 
thrombin binding aptamers, we introduce chemical modifications in the reporter 
aptamer, obtaining a novel ligand that loses its activity upon the UV exposure. As a 
result, by using the light to inactivate the reporter aptamer we developed a detection 
approach that was not only ultrasensitive but also capable of maintaining unaffected the 
protein of interest, as detailed in the chapter 3. 
Finally, we selected a DNA aptamer against the food allergen gliadin through the 
SELEX process and we demonstrated its functionality for the detection of gliadin using 
aptaPCR. A competitive assay was set up, where different concentrations of analytes 
free in solution competes for the aptamer with a standard concentration of gliadin 
adsorbed on a microtiter plate. Upon its elution from the plate, the aptamer was used as 
template for a qPCR as detailed in chapter 4. 
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II.I | ABSTRACT 
A real-time apta-PCR for the ultrasensitive detection of thrombin is reported, where 
the thrombin aptamer acts not only as a biomolecular recognition element, but also as a 
label for amplification via real-time PCR. Aptamers can be easily converted to a 
reporter agent for detection by real-time PCR, simply via flanking of the aptamer’s 
recognition moiety with primer sequences. The reported technique has the advantage of 
the ultrasensitivity achievable with immuno-PCR, but without the complications of 
addition of a DNA label, and is a technique generically applicable to all aptamers. Here, 
we use a sandwich format, where two existing thrombin binding aptamers with distinct 
binding epitopes have been utilised to capture and detect thrombin in a streptavidin-
coated microtiter plate. The amount of thrombin is calculated from real-time PCR 
analysis of eluted captured reporter aptamer. However, the technique can also be used 
for aptamer–antibody sandwiches, or simply with single aptamers. A greater than 20 
000-fold increase in sensitivity is achieved, highlighting the potential of this approach 
for the detection of very low levels of target analytes. The use of the aptamer itself as 
the reporter molecule eliminates the necessity of laborious enzyme/DNA labelling, 
facilitating a significantly more straightforward assay with a vastly enhanced sensitivity. 
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II.II | INTRODUCTION 
Biomolecular recognition elements have been exploited in detection systems for a 
wide variety of applications ranging from food quality control to clinical diagnostics1. 
Antibodies have been widely used as selective and specific biocomponents, being 
routinely used in enzyme linked immunosorbent assays (ELISA), easy-to-use, sensitive 
assays applicable to the detection of a vast number of analytes. Despite the enor- 
mously advantageous properties of antibodies, they do suffer from some drawbacks. 
Aptamers are artificial nucleic acid ligands, specifically generated against certain 
targets, such as amino acids, drugs, proteins or other molecules. For the generation of 
artificial ligands, they are isolated from combinatorial libraries of synthetic nucleic acid 
by exponential enrichment, via an in vitro iterative process of adsorption, recovery and 
re- amplification known as SELEX (Systematic Evolution of Ligands by EXponential 
enrichment)2. Indeed, the number of reports of the use of aptamers for analytical 
applications has risen exponentially over the last 15 years, and there are many promises 
that aptamers will rival antibodies for use in simple, rapid and sensitive assay systems 2-
4. Aptamers have several advantages over antibodies as recognition elements— firstly, 
SELEX is carried out in vitro, avoiding the need for animals, and aptamers can also be 
selected against non-immunogenic and toxic targets, as the process does not rely on the 
induction of an animal immune system, as in the case of antibody generation. Moreover, 
SELEX can be manipulated to produce aptamers to a specific region of the target, which 
is sometimes not possible with antibodies, as the animal immune system inherently 
hones the epitopes on the target molecule. SELEX can be carried out under non- 
physiological conditions, providing aptamers that will function under these conditions 
(e.g. in the presence of solvent, low pH), and aptamers can recover their native 
conformation after denaturation. Aptamers with different binding domains or with 
binding characteristics that can specifically recognize an aptamer target complex can be 
specifically designed. Demonstrating their increased flexibility as compared to anti- 
bodies, aptamers can be formatted into molecular beacon structures4-6 and one of the 
major advantages of aptamers is their flexibility to adapt to different assay formats. 
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The immuno-polymerase chain reaction (immuno-PCR), first reported in 1992, is a 
method for the ultrasensitive detection of analytes, which combines the selectivity of 
immunoassay techniques with the extremely high efficiency of nucleic acid 
amplification techniques and highly sensitive approaches to detect the amplified 
material7. In immuno- PCR, the reporting antibody is labelled with DNA, either 
directly, or via a biotin–streptavidin bridge. A study has been carried out to compare the 
different assemblies, concluding that antibodies directly labelled with DNA offer better 
sensitivity and reproducibility than those labelled via the biotin–streptavidin bridge8. 
This combination of PCR can lead to an increase in sensitivity of up to five orders of 
magnitude greater than those previously reported through the use of standard detection 
systems9. There have been many developments in immuno-PCR since its first report, 
and these developments have been extensively reviewed elsewhere10-12. In summary, the 
developments have concretely demonstrated that the initial report of 1992 is applicable 
to the ever-increasing demands of routine diagnostics and several commercial immuno-
PCR kits are now available. Many of the reported developments have led to significant 
increases in assay sensitivity, with some reports of dramatic improvements of a greater 
than 100 000-fold enhancement in detection limit compared to conventional ELISA13-15. 
One of the more interesting of these developments has been the use of real-time PCR 
for combined amplification and highly sensitive detection16. 
Despite the demonstration of immuno-PCR in various applications, there are some 
drawbacks with this approach, namely the requirement to link nucleic acids directly to 
antibodies, or via biotin–streptavidin linker bridges, as well as the potentially high 
background due to non-specific binding of the nucleic acid–antibody conjugates to solid 
phases17, 18. Some alternative approaches have been reported, where labelling of the 
antibody with DNA is not required, such as that of Banin et al., where double-stranded 
5’-phosphorylated DNA is used as a substrate for an alkaline phosphatase (ALP) label, 
which takes advantage of the substrate specificity of an exonuclease for this form of 
DNA. The ALP label removes the 5’-phosphate groups, and the DNA is consequently 
not degraded by subsequent exonuclease treatment. Any nucleic acid amplification 
technique can then be used to amplify and detect this non-degraded, ‘‘protected’’ 
DNA19. 
In this study, as a model, we report a real-time apta-PCR assay system based on the 
double aptamer recognition of thrombin. The apta-PCR is a further advancement and 
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simplification of immuno-PCR, where a single aptamer molecule has the dual function 
of being both a biorecognition and reporter molecule. A sandwich assay was developed 
with a biotinylated 29-mer aptamer immobilised on streptavidin- coated microtiter 
plates to capture the target thrombin, and a second 15-mer reporter aptamer, which was 
extended at both flanking sites to include primer sequences for PCR amplification. 
 
Figure II-1 A SCHEMATIC REPRESENTATION OF REAL-TIME APTA-PCR. This assay is similar to a sandwich ELISA 
where the antibodies are replaced by aptamers one aptamer (TBA29) is immobilized via biotin onto a streptavidin-
coated microtiter plate to capture the target, while the other aptamer (TBA15), flanked by primer sequences for 
amplification, is used as a reporter probe. Detection is then achieved by eluting the secondary aptamer for 
subsequent amplification through real-time PCR. 
There have been several reports of the use of double aptamer recognition as a 
sandwich assay for the detection of thrombin. The advantage of using sandwich assays 
is the combination of sensitivity and selectivity in the same assay format. Two different 
aptamers were used, one 15-mer aptamer having the sequence, 5’-
GGTTGGTGTGGTTGG-3’, and the other one a 29-mer aptamer, 5’-AGTCCGTGG- 
TAGGGCAGGTTGGGGTGACT-3’20, 21. In all of the reports detailed below, the 15-
mer aptamer was used to capture the target thrombin and the 29-mer aptamer was 
conjugated to different labels as the reporter aptamer. 
Ikebukuro et al. first reported the double sandwich aptamer assay using 
electrochemical detection and a pyrroloquinoline quinone (PQQ)-dependent glucose 
dehydrogenase label, achieving a detection limit of 1 mM22, and the team subsequently 
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improved the detection limit to 10 nM23. Mir et al. reported the electrochemical 
detection of an enzyme-labelled sandwich format24. In another report using the double 
aptamer sandwich format, the enzyme label was replaced with cadmium sulfide (CdS) 
quantum dots, and using potentio- metric detection, an improved detection limit of 0.14 
nM was obtained25. A further improvement in the detection limit to 0.02 nM was 
achieved using gold nanoparticles as the label, with impedimetric detection26. In a more 
recent report, an electrochemical magnetic bead-based assay using the double aptamer 
sandwich and a streptavidin–ALP conjugate of the reporting aptamer, achieving a 
detection limit of 450 pM27. A significant improvement in detection limit to 1 fM, was 
achieved using tris(2,2’-bipyridyl) ruthenium(II)-doped silica nanoparticles and 
electrochemiluminescence detection28. Despite the admirable detection limits that have 
been achieved with these reported approaches, they all have a definitive drawback in 
that it is necessary to prepare conjugates of oligomers to the different labels and this can 
pose some difficult problems in purification of the conjugates, as well as difficulties in 
upscaling to mass production. 
Fischer et al.29 recently reported a sandwich assay system based on detection of the 
reporter aptamer using real-time PCR or rolling-circle amplification (RCA). The 
reported approach was first demonstrated using a biotinylated target analyte, which is 
linked to streptavidin-coated magnetic beads and then exposed to a thrombin-binding 
aptamer, which, following magnetic separation, is amplified. They further extend the 
method to the use of streptavidin-coated magnetic beads linked to a biotinylated anti-
thrombin antibody, which captures the target thrombin, and the subsequently bound 
thrombin binding aptamer is isolated via magnetic separation and detected via real-time 
PCR/RCA, achieving a detection limit of 10 pM. 
In the approach we report here, we use a sandwich assay with the 29-mer aptamer 
immobilised as a capture biorecognition element and the 15-mer aptamer flanked by 
primer- specific sequences as a reporter aptamer, which is directly used as the label. 
This is facilely provided via synthesis, and thus completely avoids any problems 
encountered during conjugation and subsequent purification, without sacrificing 
specificity or sensitivity. An 20000-fold enhancement in sensitivity is achieved, with a 
demonstrated detection limit of 450 fM achieved using the apta-PCR, as compared to a 
detection limit of 5 nM attained with thrombin detection using the sandwich format and 
an enzyme label22, 30. The reported approach is applicable to all aptamers, independent of 
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whether there exists double aptamers against the target, and the technique can thus be 
applied to the detection of very low concentrations of target analytes, which is garnering 
ever increasing importance in pre- emptive medicine and the early diagnosis of disease. 
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II.III | MATHERIALS AND METHODS 
II.III.I. MATERIALS AND INSTRUMENTATION 
Biotinylated and non-modified oligonucleotides were synthesized by MWG-
Biotech. Thrombin, human serum albumin (HSA) and Tris-buffered saline–Tween 20 
(TBS-T) were purchased from Sigma. Streptavidin-coated 96 well titer plates were 
obtained from Thermo Scientific (Fisher Scientific). Real-time PCR analyses were 
performed on an Applied Biosystems HT-7900 using SYBR green labelling procedure 
with a power sybr kit (Applied Biosystems). The PCR was performed on a Biorad 
Icycler thermal cycler and agarose gel images were captured in a Biorad gel imaging 
system. Taq polymerase was obtained from Invitrogen. A Biacore 3000 was used for 
surface plasmon resonance (SPR) analysis. The CM5 sensor chip was a 
carboxymethylated dextran surface covalently bound to gold surface. 
II.III.II. OLIGOMER SEQUENCES 
The sequences of oligomers used are listed in Table 1. TBA29, referred to as 
‘capture aptamer’, represents the 29-mer thrombin-binding aptamer reported by Tasset 
et al.21 and TBA15M, referred to as ‘reporter aptamer’ is the thrombin- binding 15-mer 
aptamer reported by Bock et al.,20 flanked by primer sequences for amplification at the 
50 and 30 ends. 
II.III.III. SURFACE PLASMON RESONANCE BINDING ANALYSIS 
The binding affinities of the aptamers were analysed by SPR at 25ºC by a Biacore 
3000 system using CM5 chips (Biacore). Biotin-modified TBA15 and TBA29 aptamers 
were immobilized on streptavidin-covered CM5 chips (Biacore) by injection at a 5 mM 
concentration in TBST buffer (pH = 7.5), to achieve an increase of approximately 1000 
RU. Binding analysis was performed by primarily flowing 100 nM thrombin, over the 
sensor chip at 15 µL min-1 rate for 180 s. This was followed by an injection of 100 nM 
of the reporter aptamer, again applied for 180 s at a flow rate of 15 µL min-1. The 
running and binding buffers were 100 mM NaCl, 5 mM MgCl2, 5 mM KCl, 0.01% 
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Tween 20, 10 mM Tris (pH 7.4). The chips were regenerated by 50 mM NaOH. A 
channel without an immobilized capture aptamer was used as a control. 
II.III.I. APTA-PCR ASSAY 
TBS-T buffer was used for all binding and washing steps of the assay, and all 
incubations were carried out at 37ºC with agitation. 50 µL of biotinylated TBA29 was 
added to each well of a Nunc streptavidin-coated microtiter plate for 1 h. The plate was 
then washed three times with the same buffer and incubated in a thrombin or HSA 
solution in buffer, as detailed above, for 1 h. The reporter aptamer was then added to 
each well of the washed plate and incubated for another hour. Following thorough 
washing to remove any non-specifically bound reporter aptamer, the bound reporter 
aptamer was then eluted via incubation for 15 min in 50 µL of 200 mM NaOH, 
followed by neutralization with acetic acid. 5 µL of the elution was directly used in the 
PCR/real-time PCR reactions. 
Name Sequence (from 5’- to -3’) Mer 
Bio-TBA15 Biotin-C6-GGTTGGTGTGGTTGG 15 











Table II-1 SEQUENCES OF APTAMERS USED IN AFFINITY STUDIES AND APTA-PCR. 
II.III.II. STANDARD PCR ANALYSIS 
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Standard PCR reaction conditions used 50 µL volume and the amplicons were 
analyzed in 3% w/v agarose gels. 
II.III.III. REAL-TIME PCR ANALYSIS 
Real-time PCR reactions were performed in 20 µL volume in an Applied 
Biosystems 7900-HT Fast real-time PCR system with Power SYBR Green kit (Applied 
Biosystems). The results were analyzed by Applied Biosystem SDS 2.2.2 Analysis 
software to calculate the amount of reporter aptamer present in the samples. The PCR 
cycle consisted of an initial denaturation step at 95 1C for 2 min followed by 35 cycles 
of 95 ºC for 30 s, 58 ºC for 30 s and 72 ºC for 30 s. 
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II.IV | RESULTS AND DISCUSSION 
Aptamers were first used in combination with antibodies for a sandwich assay by 
Drolet et al.31 in which VEGF was detected in the serum by capturing the target on 
immobilized antibodies and using a VEGF-aptamer conjugated to fluorescein as 
detecting element. This study did not exploit the potential of aptamers in sandwich 
assays, but showed the possibilities of implementing aptamers in microtiter assays. 
Since then, there have been many reports of aptamer- incorporated assays in similar 
systems using fluorescent, electrochemical, redox agents or PCR and rolling circle 
detection systems. Among them, Ikebukuro et al.22 developed a double aptamer 
sandwich assay by conjugating glucose dehydrogenase to TBA29 with an 
electrochemical detection system to achieve a 1 µM detection limit, and as outlined in 
the introduction, several approaches exploiting different labels have improved on this 
detection limit using PCR. An approach for the ultrasensitive detection of thrombin 
using PCR/RCA was recently reported, but this approach used a capture antibody, 
which is required to be functionalised with a magnetic particle to facilitate efficient 
separation of bound and unbound reporter aptamer29. 
Here, we report on the ultrasensitive detection of thrombin by exploiting a new 
method of real-time apta-PCR, which is applicable to all aptamers for the detection of 
very low levels of target molecules. To demonstrate the concept, we modified the 
flanking regions of TBA15 to include PCR primers for the simultaneous recognition 
and quantification of thrombin molecules captured on solid surfaces. As shown in Fig. 
1, the approach exploits an immobilised thrombin-binding aptamer (TBA29), the 
capture aptamer, on a streptavidin- coated microtiter plate. Consequently the captured 
thrombin molecules were incubated with a second thrombin-binding aptamer 
(TBA15M), the reporter aptamer, which is known to be directed against a different area 
of the thrombin target. Following incubation of the sandwich, the reporter aptamer was 
eluted, and detected qualitatively by traditional PCR and electrophoresis, and 
quantitatively using real-time PCR. 
II.IV.I. ASSAY DESIGN 
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In order to elucidate the optimum format for the assay, SPR analysis was carried out 
to determine the kinetic constants of TBA15 and TBA29 for the target thrombin. We 
wished to determine the respective KD and kon/koff values in order to evaluate which 
aptamer should be used as a capture aptamer according to lower potential detectability 
and lower koff. Using a site-directed mutagenesis approach, it has been demon- strated 
that TBA15 binds to the fibrinogen recognition site, which is determined to be exosite I 
(Asp21)32. This binding configuration has been confirmed by NMR33. TBA29 was 
shown to bind to heparin-binding exosite (exosite II) by photocrosslinking and 
competition experiments21, and the core binding site of the aptamer has a very similar 
sequence to TBA15. However, TBA29 has been reported to have 20 to 50 times better 
binding affinity to thrombin as compared to TBA15. Recently, Tang et al.34 studied the 
binding of both aptamers in detail using SPR analysis, confirming separate binding sites 
of two aptamers by simultaneous binding in real- time. They reported a lower affinity of 
immobilised TBA29, as compared to immobilised TBA15, but postulated this to be due 
to the lack of a spacer. In a similar approach, we tested the design of the double aptamer 
sandwich assay using SPR analysis of simultaneous binding of both aptamers in order 
to determine the optimal configuration for the apta-PCR, and the affinity and kinetic 
constants for each immobilised aptamer were determined (Fig. 2). 
 
Figure II-2 SENSORGRAMS OF IMMOBILISED TBA15 AND TBA29 WITH VARIOUS CONCENTRATIONS OF THROMBIN. Data 
was used to calculate affinity and kinetic constants 
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Table 2 shows that TBA15 has an affinity constant of 421 nM and TBA29 a 
constant of 4.91 nM when they are immobilized on a streptavidin-coated surface of a 
Biacore chip. These KD values are far higher than those obtained by Bock et al.20 and 
Tasset et al.21, of 26 and 0.5 nM for TBA15 and TBA29, respectively. This, however, is 
to be expected, as these KD values were obtained for the aptamers in solution, whereas 
the KD values obtained here are for the immobilised aptamer, which would be expected 
to have limited spatial flexibility, and consequent a lower affinity. The far lower KD 
value obtained here with immobilised TBA29 would indicate it is the better of the two 
to have as the capture aptamer. In this work, we have incorporated a C6 spacer to 
facilitate the minimum possible steric hindrance of the immobilised aptamer, and it is 
presumably the presence of this spacer that obviates the decreased affinity of 
immobilised TBA29 compared to immobilised TBA15, as reported by Tang et al.34  
 KD  [nM] Kon [×104 •M-1•s-1] Koff [×10-3•s-1] 
TBA15 421 2.27 9.54 
TBA29 4,91 58,2 2,86 
Table II-2 AFFINITY AND KINETIC CONSTANTS FOR IMMOBILISED BIOTINYLATED TBA15 AND TBA29. 
Moreover, importantly, there is a clear difference in the dissociation kinetics of the 
two aptamers, with TBA29 having almost three times lower koff and 25 times higher kon 
values, thus demonstrating that TBA29 resulted in a more stable complex with thrombin 
than TBA15, further supporting that TBA29 is preferable as the capture aptamer. In 
order to confirm that the double aptamers could simultaneously bind to thrombin, and 
that the modification of TBA15 with the flanking primers did not affect its ability to 
bind to thrombin, a sequential immobilization of TBA29 and capture of thrombin, 
followed by TBA15M, was detected using SPR (Fig. 3). Thrombin and the 
corresponding modified detection aptamer were injected over immobilized aptamers at 
100 nM concentrations, and the corresponding molecular interactions were detected and 
quantified. The SPR analysis showed that modified aptamer (TBA15M) and TBA29 
could bind simultaneously to thrombin with comparable KD values to original TBA 
aptamers. Additionally, analysis was carried out to ensure that there was no binding 
between the two aptamers in the absence of thrombin. Biotin-labelled TBA29 was 
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immobilized on sensor chips and modified reporter aptamer TBA15M was injected over 
the sensor chip, but no interaction was observed. 
 
Figure II-3 BINDING ASSAY BETWEEN TBA29, TBA15M AND THROMBIN BY SPR. Biotinylated TBA29 was 
immobilized on a CM5 chip and 100 nM thrombin and TBA15M were injected at the indicated points. The 
formation of the aptacomplex of TBA29-thrombin-TBA15M could be followed in real-time.  
 
Figure II-4 THE DETECTION OF ELUTED REPORTER APTAMER TBA15M BY STANDARD PCR. Lanes 1–12 are the PCR 
results of samples prepared in microtiter plates, as described in the materials and methods section, with a serial 
dilution starting from 100 nM thrombin sample to 0.1 nM. Lane 13 is the control in the absence of thrombin, with 
500 nM TBA15M, and lane 14 is the control with 50 nM TBA15M. 
 
II.IV.II. OPTIMIZATION OF ASSAY CONDITIONS FOR PCR DETECTION 
A range of concentrations of biotinylated TBA29 (from 1 µM to 10 nM), TBA15M 
(from 10 to 500 nM) and target thrombin (100 nM) were tested in a microtiter assay to 
determine the optimum conditions of the assay. The optimised concentrations of capture 
and reporter aptamer were then applied to determine the detection limit by standard 
PCR detection. The presence of amplicons was analyzed by 3% w/v agarose gel 
electrophoresis. An example of the analysis is shown in Fig. 4. A specific band at 56 bp 
was used as evidence of the detection aptamer captured on thrombin and compared to a 
control sample without thrombin. A decrease in band intensity was a qualitative 
indication for the range of capture and detection aptamer concentrations to be used in 
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the set-up of the real-time apta-PCR. The results showed that the concentration of 
capture aptamer at concentrations higher than 50 nM was enough to detect the presence 
of reporter aptamer by standard PCR. Concentrations of reporter aptamer over 200 nM 
resulted in unspecific bands in control conditions. Thus, the optimum concentrations of 
TBA15M and TBA29 to be used in a standard apta-PCR procedure were 100 nM and 
500 nM, respectively. However, as can be seen in lane 13 in Fig. 4, which represents a 
control where no thrombin is present, this high concentration of reporter aptamer results 
in a low level of non-specific binding/adsorption of the reporter aptamer. However, 
when a lower reporter aptamer concentration of 50 nM was used (see lane 14 in Fig. 4), 
detection of thrombin concentrations as low as 1 nM was possible, with no non-specific 
binding/adsorption observed, and this concentration was thus applied in the real-time 
apta-PCR. The minimum detectable amount with standard PCR was deter- mined to be 
0.1–1 nM. 
II.IV.III. DETERMINATION OF THE DETECTION LIMIT BY REAL-TIME PCR 
In real-time assays, a detection aptamer at a concentration of 50 nM was used to 
decrease the unspecific background. An example of real-time analysis results is shown 
in Fig. 5 and the eluted TBA15M was directly used in real-time PCR quantification. 
 There were clear differences in the Ct values for thrombin concentrations of 1 nM, 
100 pM and 500 fM. 150 fM thrombin was indistinguishable from the control samples 
in the absence of thrombin and TBA29. This could be due to a low level of unspecific 
binding of the reporter aptamer in microtiter wells after washing. Fig. 5 shows how Ct 
values form separate groups by increasing the thrombin amount in assay procedures for 
fM, pM and nM concentration samples. A graph of thrombin concentration vs. Ct 
values was used to determine the LOD value of the real-time apta-PCR as 450 fM, 
representing an impressive enhancement in sensitivity of 20 000 fold as compared to a 
conventional enzyme linked aptamer assay (ELAA)30. 
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Figure II-5 REAL-TIME PCR ANALYSIS OF ELUTED DETECTION APTAMER AFTER THE DOUBLE APTAMER SANDWICH 
ASSAY. The error bars represent the standard deviation of 3 independent experiments. The inset represents the 
normalised Ct values i.e. 1-(Ct sample/Ct no template control), of the values obtained for a range of thrombin and 
HSA concentrations. 
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II.V | CONCLUSIONS 
We report here a real-time apta-PCR for the ultrasensitive detection of proteins, 
using thrombin as a model target analyte. In this approach, we use a sandwich assay 
using an immobilised 29-mer aptamer, which interacts with the heparin-binding exosite 
of thrombin as a capture biorecognition element, and a 15-mer aptamer, which interacts 
with the fibrinogen recognition site of the thrombin, flanked by primer specific 
sequences as a reporter aptamer. This reporter aptamer is directly used as the label, 
which is facilely provided via synthesis, and thus evades any problems encountered 
during conjugation and subsequent purification, without sacrificing specificity or 
sensitivity. An 20000-fold enhance- ment in sensitivity is achieved with a demonstrated 
detection limit of 450 fM using the apta-PCR, as compared to a detection limit of 5 nM 
attained with thrombin detection using the sandwich format and an enzyme label22. 
The reported approach is applicable to all aptamers, independent of whether there 
exists double aptamers against the target, and the technique can this be applied to the 
detection of very low concentrations of target analytes, which is garnering ever 
increasing importance in pre-emptive medicine and the early diagnosis of disease. 
Ongoing work is focused on the application of this technique to single aptamers, to 
demon- strate the flexibility of the reported real-time apta-PCR for the ultrasensitive 
detection of proteins. 
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III.I | ABSTRACT 
While many diagnostic assay platforms enable the measurement of analytes with 
high sensitivity, most of them result in a disruption of the analyte’s native structure and, 
thus, in loss of function. Consequently, the analyte can be used neither for further 
analytical assessment nor functional analysis. Herein we report the use of caged 
aptamers as templates during apta-PCR analysis of targets. Aptamers are short nucleic 
acids that fold into a well-defined three-dimensional structure in which they interact 
with target molecules with high affinity and specificity. Nucleic acid aptamers can also 
serve as templates for qPCR approaches and, thus, have been used as high affinity 
ligands to bind to target molecules and subsequently for quantification by qPCR, an 
assay format coined apta-PCR. Caged aptamers in turn refer to variants that bear one or 
more photolabile groups at strategic positions. The activity of caged aptamers can thus 
be turned on or off by light irradiation. The latter allows the mild elution of target-
bound aptamers while the target’s native structure and function remain intact. We 
demonstrate that this approach allows the quantitative and subsequently the functional 
assessment of analytes. Since caged aptamers can be generated emanating from 
virtually every available aptamer, the described approach can be generalized and 
adopted to any target–aptamer pair and, thus, have a broad applicability in proteomics 
and clinical diagnostics. 
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Introduction 
Immuno-polymerase chain reaction (immuno-PCR) enables the ultrasensitive 
detection of analytes via the combination of the selectivity of antibodies with the high 
efficiency and sensitivity of nucleic acid amplification methods.1 Immuno-PCR utilizes 
a reporter antibody equipped with a short DNA strand, which is employed as a template 
for quantitative PCR (qPCR). Recent developments in the field have demonstrated that 
immuno-PCR addresses the increasing demands of diagnostic assays achieving a 
significant increase in sensitivity, culminating in a more than 100,000-fold enhancement 
of detection limits as compared to conventional ELISA. 2-6 However, immuno-PCR 
relies on the availability of high affinity antibodies and requires chemical conjugation of 
the antibody to reporter oligonucleotide tags. In the past twenty years, nucleic acid 
aptamers have emerged as powerful rivals to antibodies for use as diagnostic reagents. 
Aptamers are short nucleic acids that fold into a well-defined 3D-structure upon which 
they interact with target molecules with high affinity and selectivity.7 Aptamers can be 
identified by an in vitro selection approach, termed SELEX (Systematic Evolution of 
Ligands by EXponential enrichment),8 and have been reported to interact with a diverse 
set of target molecules, such as peptides, proteins, drugs, organic and inorganic 
molecules or even whole cells9-13. Many of the aptamers reported to date reveal 
affinities for their target molecules, comparable to, if not better than respective 
monoclonal antibodies, with picomolar Kd-values.13, 14 Furthermore, the specificity of 
aptamer recognition has been observed, facilitating a 10,000-fold to 12,000-fold13, 15 
discrimination of cognate target molecules and related structures. The synthetic nature 
of aptamers enables their site-directed modification, which clearly sets them apart from 
antibodies. For example, aptamers can be generated as molecular beacon structures or 
equipped with functional tags for rapid adaptation to diverse assay formats without loss 
of aptamer activity. Consequently, due to their nucleic acid nature an approach termed 
aptaPCR has been developed. AptaPCR employs the dual function of aptamers acting 
both as a selective ligand for target molecules and as a template for qPCR. Aptamers are 
exceptionally well suited for this approach and virtually every aptamer identified to date 
can be used without laborious optimization procedures. Most importantly, this approach 
bypasses the mandatory conjugation of antibodies with DNA-reporter tags exploited in 
immuno-PCR, which can interfere with the recognition properties of antibodies. 
Several reports have been described that use the template and recognition properties 
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of aptamers, while different separation methods to enrich for the bound target have been 
employed.  
 
Figure III-1 A) PROPOSED SECONDARY STRUCTURE OF THE HD22 APTAMER, WHICH BINDS (ACTIVE) 
THROMBIN VIA EXOSITE II. B) EXTENSION OF THE APTAMER WITH A GNRA-TETRALOOP SEQUENCE 
(GTAA) AND FURTHER COMPLEMENTARY NUCLEOTIDES INDUCE HAIRPIN FORMATION AND, THUS, 
UNFOLDING OF THE APTAMER (INACTIVE). C) ADDITION OF PHOTO-LABILE GROUPS (O-
NITROPHENLYPROPYL – NPP AND O-NITROPHENYLETHYL –NPE) AT DEFINED POSITIONS (G1, G2, AND C4) 
PREVENTS HAIRPIN FORMATION AND KEEPS THE APTAMER ACTIVE. Inactivation is achieved through 
irradiation with light (λ = 365 nm), whereas the photo-labile groups are removed and hairpin formation 
is induced. D) After recognition of thrombin the caged aptamer is irradiated and thus will be release for 
qPCR analysis whereas the captured thrombin can be further assessed for specific activity. 
Most of the described assays take advantage of the unique amplification properties 
of aptamers, whereas the captured aptamer were amplified using qPCR or rolling circle 
amplification16-20 as well as proximity ligation assays.21-23 We have recently employed 
two well-known thrombin binding aptamers and extended aptaPCR towards a 
sandwich-like assay format.24 Most of the described assays for analyte detection make 
use of denaturing conditions to elute the bound aptamers from their target molecule, 
thereby potentially leading to target inactivation. Consequently, the target cannot be 
applied for further analyses, and to ensure that the functional integrity is maintained, the 
implementation of mild elution methods that allow an efficient disruption of aptamer-
UNIVERSITAT ROVIRA I VIRGILI 
REAL-TIME APTAPCR: A NOVEL APPROACH EXPLOITING NUCLEIC ACID APTAMERS FOR ULTRASENSITIVE DETECTION 
OF ANALYTES FOR CLINICAL DIAGNOSTIC AND IN FOOD ANALYSIS 
Alessandro Pinto 
DL:T. 288-2012  
 
Alessandro Pinto | PhD Dissertation  
55 
target interactions for the liberation of the aptamer for qPCR and the native target for 
further functional investigations, is required. One approach makes use of antisense 
molecules that hybridize with the aptamer, thereby disrupting its active conformation 
and another reported alternative employs so-called caged aptamers. Caged aptamers 
bear photolabile groups at strategic positions and, thus, their target recognition 
properties can be controlled by light irradiation.25-28 In this way, we hypothesize that 
caged aptamers can be designed to recognize and bind a target molecule and can 
consequently be liberated upon irradiation. The released aptamer can subsequently be 
used as template for aptaPCR and the remaining captured target analyte for functional 
analysis (Scheme 1). In the present work we describe the entire route to accomplish the 
aforementioned strategy. Starting from the well-known aptamer HD22 that recognizes 
thrombin’s exosite II, we illustrate the generation of a caged aptamer-variant, which 
binds thrombin with high affinity, but can be released by light irradiation. Using this 
molecule we established a ‘direct’ and ‘sandwich’-type kind of aptaPCR assay. 
Furthermore, we demonstrate that after light irradiation the target protein’s enzyme 
activity remains functional. This model system can be generalized and adopted toward 
the detection of a series of analytes for which quantitative, qualitative and functional 
analysis in one assay format is applicable and desirable.  
III.II | EXPERIMENTAL SECTION 
III.II.I. REAGENTS 
Unmodified oligonucleotides, PCR primers (forward: 5’-
AAAGTCCGTGGTAGGGCA-3’; reverse: 5’-TCTCTTCGAGCAATCCTCAC-3’) and 
biotinylated HD1 aptamer (5’-GGTTGGTGTGGTTGG- biotin-3’) were synthesized 
and HPLC purified (Ella Biotech, Martinsried, Germany). Human α -thrombin was 
purchased from Cell Systems Biotechnologie Vertrieb GmbH (Troisdorf, Germany). 
Thrombin and Bovine serum albumin (BSA) were purchased from Sigma-Aldrich 
(Germany). Fluorogenic peptide substrate Pefafluor TH (H-D-CHA-Ala-Arg-AMC) 
was purchased from Loxo (Dossenheim, Germany).  Streptavidin was purchased from 
Applichem (Darmstadt, Germany). E. coli tRNA was purchased from Roche 
Diagnostics (Germany). Taq DNA polymerase and PCR reagents was purchased by 
Invitrogen (Germany). B&W buffer  (binding and washing buffer) consists of 137 
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mmol/L NaCl, 2.7 mmol/L KCl, 9.6 mmol/L Na2HPO4, 1.5 mmol/L KH2PO4 and 3mM 
magnesium chloride at pH 7,4. 
III.II.II. FILTER RETENTION ANALYSIS 
The sequence of interest was radiolabelled at the 5’-end with γ 32-ATP using T4 
polynucleotide kinase (New England Biolabs GmbH, Germany). After one hour 
incubation at 37°C, unreacted γ 32-ATPs were removed using G25 microspin columns 
(GE healthcare, Germany) following the manufacturer's instructions, and the 
radioactively labeled aptamer was subsequently analyzed via electrophoresis on a 12% 
polyacrylamide denaturing gel. To determine the dissociation constant of the sequences 
studied, 0,4 nM of radiolabeled nucleic acids were mixed with increasing concentrations 
(0 to 1µM) of human α-thrombin and incubated at 37°C for 30 minutes in B&W buffer 
in the presence of 1mg/mL of BSA and 10µM of tRNA.  After incubation the mixture 
was filtered thought a 0.45µM nitrocellulose membrane (Whatman, Germany), 
previously activated with 0.4 M of potassium hydroxide and rinsed with 600µL B&W 
buffer. Finally, the nitrocellulose membrane was washed with 800µL of B&W buffer, 
dried and exposed on a storage phosphor screen. Following overnight exposure, the 
screen was analyzed using a FUJIFILM FLA-3000 with AIDA Image software 
(Fujifilm, Germany). To characterize the affinity of the HD22 derivatives, 0.4 nM of 
radioactively labeled HD22 was incubated with 10nM of thrombin in the presence of an 
increasing amount (0-1 µM) of each of the unlabelled derivatives. Following a 30 
minute incubation at 37°C in B&W buffer in the presence of 1mg/mL of BSA and 10 
µM of tRNA, the mixture was filtered and analysis carried out as described above.  Two 
independent measurements were performed for each derivative.  
III.III | SYNTHESIS OF THE CAGED OLIGONUCLEOTIDES  
The phosphoramidite building blocks for the introduction of a caged dGNPP 29 
residue and a dCNPE 25 residue were synthesized according to established literature 
procedures. Caged oligonucleotides were synthesized on an ABI-392 synthesizer using 
standard coupling protocols. For the cleavage, aqueous ammonia (65 °C, 4 h) was used. 
The resulting crude product was purified by RP-HPLC (Nucleosil 100-5 C18, 0.1 M 
triethylammonium acetate pH 7, acetonitrile), detritylated, and again purified by RP-
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HPLC (same protocol). The identity of the oligonucleotides was established by ESI-
MS: 5'-AAGCAGTGGTAAGTAGGTTGATT-GNPPGNPPACNPETGTAA-HD22-
TCTCTTCGAGCAATCCTCAC-3': 25,681.0 Da (calc. 25,680.61), 5'-
GNPPGNPPACNPETGTAA-HD22-TCTCTTCGAGCAATCCTCAC-3': 15,548.9 Da (calc. 
15,549.14) 
III.IV | APTAPCR 
Direct aptaPCR 
A range of human α -thrombin concentrations (0 to 10nM in 0.05 M 
carbonate/bicarbonate buffer pH 9.6) were incubated on the wells of a microtiter plate 
(50µL/wells) for 30 minutes at 37°C. Following incubation, the plate was washed three 
times with B&W buffer (200 µL/wells each wash), and the surface was blocked by 
incubating the plate for 30 minutes at 37°C in the presence of Tween-20. Subsequent to 
a further washing step, 5.3amp1 was added to each well and incubated at 37°C for 30 
minutes (50 µL/well, 250 pM final concentration) in the presence of 10µM of tRNA, 
followed by a final wash with B&W buffer (800 µL/well). Finally, following the 
addition of fresh B&W buffer (50µL/well), the reporter aptamer was eluted. Elution was 
carried out in three different ways: a) incubation for 10 minutes at room temperature in 
B&W buffer b) incubation for 5 minutes at 95°C and c) irradiation with UV light (λ = 
365 nm) for 5 minutes followed by 5 minutes incubation at room temperature. 
Following elution, 1 µL of the eluted supernatant was used for successive amplification 
using qPCR. 
Sandwich aptaPCR 
Firstly, streptavidin (10µg/mL) in carbonate/bicarbonate buffer (0,05M, pH 9.6) was 
added to the microtiterplate (100µL/well). Following an overnight incubation at +4°C, 
the plate was washed with   B&W (600µL/ well), and after a one hour incubation at 
37°C in the presence of 1mg/mL of BSA in B&W buffer the 96-well plate was further 
rinsed with B&W buffer (600µL/well). Finally, the buffer was removed and the 
functionalized microtiter plate, stored at +4°C, was used within two days. Biotinylated 
HD1 aptamer was dissolved in B&W buffer to a final concentration of 500 nM and 
added to the streptavidin-coated wells of microtiterplates (100µL/well). Following one 
hour incubation at 37°C, the wells were washed with B&W buffer (600µL/well). 
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Subsequently, a range of concentrations of human α-thrombin  (0 to 10nM) were added  
(50µL/well) and incubated for one hour at 37°C.  After washing step, 5.3amp1  (2.5nM) 
was added (50µL/well) and incubated for one hour at 37°C. After thorough washing 
(800 µL/well) the caged aptamer was eluted as described for the direct assay. 
qPCR 
1µL of the elution fraction was added to 19 µL of a PCR master mix, which consisted of 20 mM 
Tris-HCl (pH 8.4), 50 mM KCl, 3mM MgCl2 100nM of forward and reverse primer, 1x final 
concentration SYBR Green I (Sigma-Aldrich, Germany), 10nM FAM (Bio-Rad, Germany) and 
0.25 units of Taq DNA Polymerase. The amplification was performed in an iCycler thermal 
cycler upgraded with the iQ5 real-time PCR detection system (Biorad, Germany) programmed 
according to the following protocol: 1 minute at 95°C, followed by 40 repetitions of 30 seconds 
at 95°C, 30 seconds at 58°C and 30 seconds at 72°C. The LoD was calculated from two 
independent experiments in which each sample was analysed in duplicate, where the LoD was 
calculated as the background value plus three times the standard deviation of the background. 
Measure of the functional integrity via thrombin activity 
1 pmol of thrombin was either captured by immobilized HD1-aptamer (sandwich assay) or 
physically adsorbed (direct assay) on the microtitre plate surface. Following incubation with the 
caged aptamer and subsequent elution, Pefafluor TH (50 µL/well, 100 µmol/L of in TBS, pH 
8.5) was added to each well of the microtiter plate and the change in fluorescence ( λ Abs= 
342nm, λEm=440nm)  after 30 minutes was taken as a measure of the functional active thrombin. 
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III.V | RESULTS AND DISCUSSION 
III.V.I. CONSTRUCTION OF A LIGHT-RESPONSIVE VARIANT OF 
APTAMER HD22 
We previously described the synthesis and characterization of a variant of the 15mer 
thrombin’s exosite I recognizing aptamer HD1, which can be switched off upon 
irradiation with light.26 However, due to its short length it would be necessary to add 
primer-binding sequences to modify HD1 to render it a suitable template for qPCR. 
















5.3amp1 5'- GGACTGTAA-HD22-TCTCTTCGAGCAATCCTCAC-3' 
Table III-1 : LIST OF OLIGODEOXYNUCLEOTIDES USED IN THIS STUDY. 
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Consequently, we thus decided to generate variants of the aptamer HD22 whose 
activity can also be switched off by irradiation with light. Emanating from our previous 
studies we synthesized variants of HD22 that bear extensions at either its 5´- or its 3´-
end, which can base pair with neighbouring nucleotides of HD22 and, thus, disrupt the 
active aptamer structure. Herein, the aptamer was extended by the means of a GNRA-
tetraloop followed by an antisense sequence of up to 9 complementary nucleotides 
(Table 1). As shown previously, this design facilitated the formation of a hairpin 
structure, which alters the conformation of HD22 and, thus, its recognition properties.25, 
26 We evaluated the recognition behaviour of the extended HD22 variants by 
competitive binding experiments, where we incubated radioactively labeled HD22 with 
a constant amount of thrombin and increasing concentrations of extended HD22 
variants. Those variants that still interact with thrombin will reduce the HD22 signal 
whereas those that fail, most likely due to hairpin formation, will have no effect on 
HD22 binding. As shown in Figure 1, the extended HD22 versions differ significantly 
with respect to their ability to compete with HD22 thrombin recognition. While 
extensions at the 3’-end have less influence on thrombin recognition, the aptamer HD22 
is sensitive toward extensions at the 5’-end. 
Addition of 5 complementary nucleotides (variant 5.3) abolishes thrombin 
recognition almost completely. In contrast, a similar extension located at the 3’-end 
(variant 3.3) still recognizes thrombin and even the addition of 9 complementary 
nucleotides at the 3’-end does not completely inactivate HD22. These data are in 
accordance with previous findings where both the length and position of an antisense 
oligonucleotide region are important factors for the perturbation of aptamer function, 
with the effect of the length and position being difficult to predict. The control variants, 
which were solely extended with the GNRA-tetraloop sequence (variants 5.5 and 3.5) 
still revealed high affinity binding to thrombin exemplified through a strong 
competition activity, which in fact, seemed to be even more efficient when compared 
with the wild type aptamer HD22. Having identified the HD22 variant 5.3 as non-active 
we next started to adopt it for a photo-elution aptaPCR setup. Therefore, we added 
primer-binding sites at either the 3´-end (5.3amp1) or at both the 3´- and 5´-end 
(5.3amp) of HD22 to enable amplification by qPCR (Table 1).  These sequences were 
chosen to be non-complementary and the primer-tethered HD22 still interacted with 
thrombin (Supporting Information). We then synthesized the caged variants of 5.3amp1 
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and 5.3amp (Scheme 1 and Table 1). To achieve this we introduced 3 photo-labile 
groups at positions G1, G2 and C4 of the extension, functioning as a temporary block of 
hairpin formation, resulting in an active HD22 variant that can be inactivated upon 
light-irradiation. Using filter retention analysis, we analyzed whether the caged variants 
functioned as predicted (Figure 2). As expected, the caged variants bind to thrombin 
with high affinity and interestingly, compared to the wild type aptamer HD22 slightly 
increased KD–values of the modified aptamers (90 nM, 5.3amp1, and 9 nM, 5.3amp), 
were oserved. Light irradiation (λ = 365 nm), however, induces a loss of the caged 
aptamers’ recognition activity and more importantly this can be also observed in the 
case of the already formed thrombin-caged aptamer complex.  
 
Figure III-2 COMPETITION OF HD22-THROMBIN INTERACTION BY HD22-VARIANTS. To evaluate the impact of the 5´-
and 3’-extensions filter retention analysis were done by incubating radioactively labeled HD22 with thrombin [10 
nM] in the presence of increasing concentrations [10 nM, 100nM, and 1000 nM] of each variant. After passing 
through nitrocellulose [0.45 µm] the retained amount of labeled HD22 was determined by phosphorimager analysis 
and quantified using ImageQuant software. 
However, the variant with extensions on both ends (5.3amp) does not react in the 
predicted way. It reveals recognition properties even in the irradiated version (Figure 
2B), which might be explained by competitive base pairing options of the 5´-extension 
with the uncaged sequence (Table 1, underlined), leading to an intact HD22 structure 
and, thus, preserved recognition properties. Due to these findings we focused on 
5.3amp1 for the further development of the photo-apta-PCR assay.  
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Figure III-3 LIGHT-DEPENDENT INTERACTION OF THE CAGED APTAMERS 5.3AMP1 AND 5.3AMP WITH 
THROMBIN. A) Filter retention analysis of 5.3amp1 with increasing concentrations of thrombin 
without (w/o hν) and after (after w/ hν and before w/ hν) irradiation (λ = 365 nm). Irradiation was 
performed either before (before w/ hν) of after (after w/ hν) incubation with thrombin. B) Filter 
retention analysis of 5.3amp with increasing concentrations of thrombin without (w/o hν) and after 
(after w/ hν and before w/ hν) irradiation (λ = 365 nm). Irradiation was performed either before 
(before w/ hν) of after (after w/ hν) incubation with thrombin. After passing through nitrocellulose 
[0.45 µm] the retained amount of labeled HD22 was determined by phosphorimager analysis and 
quantified using ImageQuant software. 
III.V.II. DIRECT AND SANDWICH APTA-PCR 
In a first step, we established a direct assay format, in which thrombin was directly 
physically adsorbed on the surface of microtiter plate wells. Thrombin-coated wells 
were subsequently incubated with increasing concentrations [0.025 nM to 500 nM] of 
5.3amp, washed and the bound 5.3amp1 was then eluted by UV-exposure (λ = 365 nm). 
The supernatant was removed and directly assayed by qPCR. The optimized 
concentration of caged 5.3amp1 was determined to be 250pM. At this concentration, the 
maximum difference between controls (absence of thrombin) and the lowest detectable 
concentration of thrombin was achieved, whilst the threshold cycle (Ct) of the control 
equaled that of the non-template control (NTC).  A detection limit of 6 femtomoles 
thrombin (120 pM) was achieved (Figure 3A). 
Secondly, the sandwich variant of the apta-PCR was employed. This makes use of a 
3’-biotinylated HD1 aptamer, immobilized on streptavidin coated microtitre plate wells. 
These were exposed to increasing concentrations of thrombin [0 – 10 nM] and after 
incubation and washing, the 5.3amp1 was added. The optimal concentrations of both 
aptamers were determined through investigating different concentrations of one aptamer 
while the other was kept constant. Interestingly, the optimal concentration of 5.3amp1 
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was found to be tenfold higher in the sandwich-assay compared to the direct assay 
approach, which can be attributed to the fact that lower levels of thrombin had been 
captured by the immobilized aptamer HD1. Concentrations of 5.3amp1 concentrations 
lower 2.5 nM result in an increase of the Ct-value comparable to those obtained from 
controls.  After thorough washing, the bound 5.3amp1 was photo-eluted and directly 
used as a template for qPCR. The detection limit was determined to be 2 femtomoles 
(40 pM), slightly improved as compared with the direct assay format (Figure 3B). Both 
assays revealed specific thrombin based detection, since control experiments using BSA 
or activated protein C (APC) instead of thrombin resulted in no signals (Figure 3C). To 
evaluate the elution efficiency of the photo-elution approach, from both the direct and 
the sandwich apta-PCR, the 5.3amp1 aptamer recovered from 10pM of thrombin 
through different elution methods was quantified via standard qPCR. Interesting, the 
results suggest than in terms of efficiency photo-elution was comparable to the thermal 
elution, being about four times more efficient then the elution at room temperature 
(Figure 3D).  
Having demonstrated the photo-aptaPCR formats we analyzed whether this 
approach allows the quantification of thrombin and its successive qualitative and 
functional assessment. To this end, the activity of thrombin in both aptaPCR assays was 
monitored before and after elution through cleavage analysis of PEFALFUOR-TH (H-
D-cyclohexylalanyl-alanine-arginine-7-amino-4-methylcoumarin), a fluorogenic 
thrombin substrate (Figure 4).30 Using this approach we demonstrated that the photo-
elution approach facilitates the quantitative detection of thrombin and that photo-elution 
of the caged aptamer does not interfere with the structural and functional integrity of 
thrombin, whilst thermal elution results in complete thrombin inactivation. The use of 
caged aptamers and, thus, a photo-elution step for aptaPCR is very promising and 
avoids the disadvantages encountered through chemical or thermal release procedures.  
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Figure III-4 THE PHOTO-APTAPCR ASSAY. Determination of the limit of detection (LoD) indicated by the red dots of 
the direct (A) and sandwich-type (B) photo-apta-PCR assay. ∆Ct-values in dependence of increasing amounts of 
thrombin are given. C) ∆Ct-values determined using 5 pmoles of BSA (light grey bars), thrombin (black bars), or 
APC (activated protein C, dark grey bars) as analytes in the direct (left) and sandwich-type photo-apta-PCR assay. 
D) Determination of the amount of 5.3amp1 detected in dependence of different elution methods. 
Furthermore the use of chemical release, for example by employing chaotroping 
reagents such as urea, requires their subsequent removal or neutralization prior to qPCR 
analysis, which in turn results in dilution of the eluted aptamer and often requires 
precipitation of the template prior to further analysis. Thermal release generally causes 
protein denaturation and degradation and, thus, protein fragments are frequently present 
in the template fraction, thus also necessitating precipitation of the eluted DNA template 
prior to further analysis. Photo-elution, however, requires only a short UV-exposure and 
no further sample treatment is required. The possibility of maintaining structural and 
functional integrity following analysis may enable many applications in diagnostic and 
proteomic approaches, where small amounts of isolated proteins have to be detected and 
quantified and then further investigated regarding functional integrity. 
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Figure III-5 THROMBIN ACTIVITY IN DEPENDENCE OF DIFFERENT ELUTION METHODS. Thrombin protease activity was 
measured by means of the cleavage of a fluorogenic peptide substrate after thermal elution (95°C, light grey bars) and 
after photo-elution (hn, dark grey bars) in either the direct (left) or sandwich-type (right) assay. The values obtained 
prior elution were normalized to 100% (before, black bars). 
III.VI | CONCLUSIONS 
In summary we have demonstrated a novel application of caged aptamers as light-
dependent templates for apta-PCR. Caged aptamers enable the disruption of analyte and 
aptamer complexes by irradiation with light (λ = 365 nm). The advantages of this 
approach, compared to conventional apta-PCR assays, are given through a 
straightforward qPCR format, where no purification steps of the eluted aptamer is 
necessary and, thus, there is minimal loss of the reporter aptamer prior to quantification. 
Moreover, the elution by irradiation maintains the analyte in its native state allowing it 
to be used for further testing. This has been exemplified in our study, where we 
investigated the functional integrity of thrombin before and after irradiation and elution 
of the aptamer for qPCR amplification. The approach introduced in this study can be 
applied to virtually every aptamer-target pair and, thus, it can be generalized to 
measuring a diverse set of clinically relevant proteins and biomarkers. This approach 
may be also applicable to analyze proteomes with spatiotemporal resolution.   
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III.IX | SUPPLEMENTARY INFORMATION 
1. Competition assays 
 
 
Figure III-6 Supplementary Figure 1: COMPETITION OF HD22-THROMBIN INTERACTION BY HD22-VARIANTS: DOSE-
RESPONSE CRUVES. To evaluate the impact of the 5´- (black) and 3’- (grey) extensions filter retention analysis was 
performed by incubating radioactively labeled HD22 with thrombin [10 nM] in the presence of increasing 
concentrations [from 0 to 1000 nM] of each variant. After passing through nitrocellulose [0.45 µm] the retained 
amount of labeled HD22 was determined by phosphorimager analysis and quantified using ImageQuant software.  
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2. Competition curve of HD22amp 
 
Figure III-7 Supplementary Figure 2: COMPETITION OF HD22-THROMBIN INTERACTION BY HD22AMP OR UNLABELLED 
HD22: DOSE-RESPONSE CURVE. To evaluate the effects of both primer regions – at 5’ and 3’end-, filter retention 
analysis was performed by incubating radioactively labeled HD22 with thrombin [10 nM] in the presence of 
increasing concentrations [from 0 to 1000 nM] of HD22amp variant (dark blue line) or unlabeled HD22 wild type 
(red). After passing through nitrocellulose [0.45 µm] the retained amount of labeled HD22 was determined by 
phosphorimager analysis and quantified using ImageQuant software.  
3. Binding isotherm of 5.3 and 3.3 compared to HD22 
 
Figure III-8 Supplementary Figure 3: BINDING CURVES OF THE 3.3 AND 5.3 VARIANT IN COMPARISON WITH THE WILD 
TYPE HD22. A) Filter retention analysis of the 5.3 (black) and the 3.3(light grey) with increasing concentrations of 
thrombin (from 0 to 1000 nM). B) Filter retention analysis of the wild type HD22 aptamer with increasing 
concentrations of thrombin (from 0 to 1000 nM). After passing through nitrocellulose [0.45 µm] the retained amount 
of labeled aptamer was determined by phosphorimager analysis and quantified using ImageQuant software.   
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IV.I | ABSTRACT 
Celiac disease (CD) is an immune mediated enteropathy triggered by the dietary 
gluten ingestion. So far, the only possible treatment is a lifelong gluten-free diet, which 
implies the need for detection methods of gluten in food. Herein we described the 
selection of the first DNA anti-gliadin aptamer reported to date, and its use for the 
detection of gliadin in foodstuff. Aptamers are short nucleic acids that bind to target 
molecules with high affinity and specificity. The aptamer selection was achieved by 
using the Systematic Evolution of Ligand by EXponential enrichment (SELEX) 
process, which permitted the screening of a vast library of a synthetic single stranded 
DNA library (1013 members) through the repetition of different rounds of amplification 
and selection. After eight rounds of selection the enriched library was cloned and 
sequenced identifying a high conserved sequence. This sequence was characterized for 
its specificity and used to set up a competitive aptaPCR assay. Here different 
concentrations of the analytes free in solution compete for the selected aptamer with a 
standard concentration of the target adsorbed on a microtiter plate. Upon its elution 
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IV.II | INTRODUCTION 
Celiac disease (CD) is an immune mediated enteropathy triggered by the ingestion 
of dietary gluten ingestion. Characterized by symptoms that can range from nausea, 
diarrhoea and weight loss to growth problems, celiac disease affects at least the 1% of 
worldwide population1. To date, Celiac disease has no cure and the only possible 
treatment is a lifelong gluten-free diet. Gluten-free foods are classified in two different 
categories: the first comprise those foods that naturally do not contains gluten, but could 
contain gluten due to accidental contamination in the production-process; the second 
comprise those foods that are rendered gluten-free. According to the Codex 
Alimentarius, the threshold of gluten in naturally gluten free-foods is 20mg/Kg dry 
mass, while the maximum content of gluten for foods rendered gluten-free is 200mg/K2. 
In both cases it is evident that gluten-free foods should be carefully verified through 
sensitive and reliable methods for the quantification of any gluten present. Hitherto, 
various Enzyme Linked ImmunoSorbent Assay (ELISA) approaches have been 
developed and are recommended due to their specificity and sensitivity3.  
ELISA relies on antibodies, which while being highly specific and having high 
affinity they require the sacrifice of host animals and are relatively expensive. 
Furthermore, they suffer from interference from reducing agents routinely used to 
extract protein from foodstuffs.  
In the early 2000s an alternative analytical approach was proposed, which relies on 
the quantification of DNA biomarkers through the polymerase chain reaction (PCR). 
The method exploits the high specificity and sensitivity of PCR to detect specific DNA 
biomarkers in gluten-rich plant cells. Despite the potential of the PCR, the method fails 
to determine the total gluten content, allowing the identification and the quantification 
of   plants cells used in the production instead.  
Herein we propose the use of nucleic acid aptamers for the detection of gluten in 
foodstuffs. In the last two decades, nucleic acid aptamers have emerged as powerful 
competitors to antibodies for use as diagnostic reagents. Aptamers are short nucleic 
acids that interact with target molecules with high affinity and selectivity4, usually 
identified by an in vitro selection approach, termed SELEX (Systematic Evolution of 
Ligands by EXponential enrichment)5. Aptamers were reported to interact with a 
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diverse set of target molecules, such as peptides, proteins, drugs, organic and inorganic 
molecules or even whole cells6-10. Many of the aptamers detailed to date reveal affinities 
for their target molecules, comparable to, if not better, than respective monoclonal 
antibodies with picomolar Kd-values10, 11. Furthermore, the specificity of aptamer 
recognition has been observed, which allows 10,000-fold to 12,000-fold10, 12 
discrimination of cognate target molecules and related structures. The synthetic 
chemical access of aptamers enables their site-directed modification, which clearly sets 
them apart from antibodies.  
Due to their nucleic acid nature an approach termed aptaPCR has recently been 
developed. AptaPCR employs the dual function of aptamers acting both as a selective 
ligand for target molecules and as a template for qPCR thus acting both as binding and 
reporter molecule. Aptamers are exceptionally well suited for this approach and 
virtually every aptamer identified to date can be applied to aptaPCR without laborious 
optimization procedures. Most importantly, this approach bypasses the mandatory 
conjugation of antibodies with DNA-reporter tags exploited in immuno-PCR, which can 
interfere with the recognition properties of antibodies. 
With the aim of achieving the cost effective and sensitive detection of gluten, herein 
we describe the first example of specific gluten detection mediated by nucleic acid 
aptamers.  
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IV.III | EXPERIMENTAL SECTION 
IV.III.I. REAGENTS 
PAGE purified DNA pool and HPLC purified primers were purchased from 
Biomers.net GmbH (Germany). Individual DNA sequences were synthesized and HPLC 
purified (Ella Biotech, Martinsried, Germany). Whole Gliadin, bovine serum albumin 
(BSA) and rabbit anti-wheat gliadin polyclonal antibody developed in rabbit were 
purchased from Sigma-Aldrich (Spain); streptavidin modified magnetic beads 
(streptavidin-Mb) were from Chemicell GmbH (Berlin, Germany) beads, E. coli tRNA 
was purchased from Roche Diagnostics (Germany). Taq DNA polymerase and all PCR 
reagents were purchased by Invitrogen (Madrid, Spain), B&W buffer (binding and 
washing buffer) consists of 10 mM Tris–HCl (pH7.5),1mM EDTA, 2M NaCl; Selection 
Buffer (SLX buffer) consist of 0.01 M phosphate buffered saline buffer pH 7.4 (PBS) 
purchased from Sigma-Aldrich (Spain) supplied with 3mmol/L MgCl2. 
IV.III.II. APTAMER SELECTION 
Plate	  preparation	  
Before each round of selection, 1 mg gliadin powder was dissolved in 1 mL PBS, 
stirred at RT for 30 minutes and centrifuged at 6000g for 10 minutes and the pellets re-
suspended in 60% (v/v) ethanol. Following incubation for 20 minutes under stirring 
conditions, the solution was further centrifuged. Afterwards the supernatant was diluted 
in carbonate/bicarbonate buffer (0,05M, pH 9.6) to a final concentration of 10 µg/mL, 
and 200 µL of this solution were incubated in each well of a NUNC Maxisorp 
microtiter plate (200µL) overnight at 37°C. After three washing steps with selection 
buffer, the well was dried. 
SELEX	  
 In the first round of selection, 5 µL – 500 pmol- of the S1 pool (5’-
GCCTGTTGTGAGCCTCCTAAC-Nx49-CATGCTTATTCTTGTCTCCC-3’) were 
heated to 95ºC for 3 minutes and subsequently cooled on ice for 10 minutes. The aliquot 
was then diluted in SLX buffer supplied with 1mg/mL of BSA and 10µM of tRNA. The 
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pool was incubated for 30 minutes at room temperature in the presence of the target 
previously immobilized on the microtiter plate. Following incubation the supernatant 
was carefully removed and the well washed three times with 200 µL of selection buffer. 
Finally, the bound DNA was eluted in water via the addiction of 50µL of Milli-Q water 
to each well and the plate was heated to 95ºC for 3 minutes. Upon collection of the 
supernatant, the elution was repeated. Finally the eluted DNA (100µL) was used as a 
template for PCR amplification in the next round of SELEX. In order to increase the 
selection stringency, in the second round a one-minute incubation in milli-Q water was 
introduced. In the third round three further washing steps with selection buffer were 
performed and in the fourth round a further incubation with milli-Q water was added. In 
this way, in the eighth round the microtiter plate was washed 24 times in selection 
buffer plus 4 incubations in milli-Q water (1 every 3rd washing). 
PCR	  amplification	  
Following each cycle, the eluted DNA was used as a template for a 1000 µL final 
volume PCR reaction. The PCR mixture contains 0.35 mM MgCl2, 0.2 mM dNTPs, 0.2 
µM forward primer (5’-GCCTGTTGTGAGCCTCCTAAC-3’), 0.15 µM biotinylated 
revers primer (5’biotin-GGGAGACAAGAATAAGCTG-3’), 0.5 mg/ml BSA and 10 
Units of Taq polymerase. The amplification was performed in an iCycler thermal cycler 
(Biorad, Spain) programmed according to the following protocol: 2 minute at 95°C, 
followed by N repetitions of 30 seconds at 95°C, 30 seconds at 54°C and 30 seconds at 
72°C. In the first cycle N=18, but starting from the second round a pilot PCR was 
performed in order to titrate the optimal number of repetition. In the pilot PCR 10 µL of 
the eluted DNA was added to 100µL final volume PCR reaction. Thus every 4 cycles of 
PCR an aliquot of the reaction was taken. Finally the quantity and quality of the PCR 
product was evaluated using gel electrophoresis. 
Strand	  Displacement	  
2.5 mg of streptavidin-Mb were taken from the stock and the storage buffer was 
removed via magnetic separation (Dynal Sample Mixer, Invitrogen, Madrid, Spain). 
Subsequently the Mbs were washed three times with 1x B&W buffer (250 µL each 
wash) and re-suspended in 500 µl of PCR-product and 500 µL of 2x B&W buffer. Upon 
incubation for 30 minutes at room temperature under moderate shaking, the sample was 
briefly centrifuged and the supernatant was removed using magnetic separation. After 
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three washes in B&W buffer, the dried Mbs were re-suspended in 100 µL of 0,1M 
NaOH and incubated for 3 minutes under gentle shaking conditions. The supernatant 
was finally recovered, titrated with 0.5M HCl and ethanol-precipitated, by  the addition 
of three volumes of 99% v/v ethanol and 1/10 volume of sodium acetate 5M, and 
incubation for 2 hours at -20ºC, followed by 15 minutes centrifugation at 15000 rpm, 
drying and resuspension in 500 µL of 70% v/v ethanol and again centrifuged for 5 
minutes.  The resultant pellet was finally re-suspended in the desired buffer.  
Monitoring	   of	   SELEX	   Evolution	   through	   Surface	   Plasmon	   Resonance	   (SPR)	  
analysis	  
BIAcore 3000 (GE Healthcare) with the BIAevalution software was used for SPR 
experiments. Proteins of interest were immobilized, via amine coupling, on separate 
channels of a CM5 sensor chip. Fist the chip was activated by EDC/NHS followed by 
an injection of the protein to be immobilized (5 µl/min for 10 min). After 
immobilization of the protein, unreacted NHS esters were deactivated by injecting an 
excess of ethanolamine hydrochloride. Unspecifically bound proteins were then washed 
from the surface with 100 mM NaOH. The single stranded DNA pool from each cycle 
of SELEX was diluted in selection buffer, to a final concentration of 50nM, and injected 
for 6 minutes at a flow rate of 10 µl/minutes followed by 3 minutes stabilization time 
and 2 minutes dissociation time. The binding of DNA was analyzed through 
corresponding changes in the refractive index of optical signals, and expressed as 
resonance units (RU). All reagents and buffers were prepared in milliQ water and were 
previously filtered. 
Cloning	  and	  Sequencing	  
DNA was cloned into the plasmid pCR2.1 using the TOPO TA Cloning® kit 
(Invitrogen, Spain) according to the manufacturer’s instructions. Colonies were 
subsequently selected and grown overnight in a culture of 5 ml LB medium under 
vigorous shaking. Plasmid clones were purified with a QIAprep Spin Miniprep kit 
(Qiagen, Spain). Purified plasmid DNA were sequenced through the GenomeLab DTCS 
Quick Start Kit (Beckman Coulter) according to the manufacturer's instructions, and 
analyzed in a CEQ8000 Beckman Coulter instrument. The sequences derived from 
SELEX procedure were aligned using Clustal (http://www.clustal.org) and T Coffee 
(http://tcoffee.crg.cat/) softwares. 
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IV.IV | APTAPCR 
Characterization	  of	  the	  candidates	  
A range of gliadin concentrations (0 to 5 µg/mL in 0.05 M carbonate/bicarbonate 
buffer pH 9.6) were incubated on the wells of a microtiter plate (50µL/wells) for two 
hours at 37°C. Following incubation, the plate was washed three times with the 
selection buffer (200 µL/wells each wash), and the surface was blocked by incubating 
the plate for 1 hour at 37°C in the presence of BSA. Subsequent to a further washing 
step, the selected sequences were added to each well and incubated at RT for 30 
minutes (50 µL/well, 500 nM final concentration) in the presence of 10µM of tRNA, 
followed by a final wash with the selection buffer (800 µL/well). Finally, following the 
addition of milliQ water (50µL/well), the reporter aptamer was heat-eluted. 
Development	  of	  the	  competition	  assay	  
10µg/mL whole Gliadin (in 0.05 M carbonate/bicarbonate buffer pH 9.6) was 
incubated on the wells of a microtiter plate (50µL/wells) for two hours at 37°C. 
Following incubation, the plate was washed three times with the selection buffer (200 
µL/wells each wash), and the surface was blocked by incubating the plate for 1 hour at 
37°C in the presence of BSA and 0.05% v/v Tween-20. Subsequent to a further washing 
step, while the plate was incubated in presence of tRNA for 1 hour at 37ºC, off plate 
100nM G33 were incubated with different concentration of gliadins (from 0 to 
50µg/mL). Following the washing of the plate, the G33 pre-incubated with gliadin free 
in solution was incubated on the plate, at RT for 30 minutes (50 µL/well) in the 
presence of 10µM of tRNA.  Following a final wash with the selection buffer (800 
µL/well), milliQ water (50µL/well) is added, and the reporter aptamer heat-eluted. 
qPCR 
1µL of the elution fraction was added to 19 µL of a PCR master mix, which 
consisted of 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 3mM MgCl2 100nM of forward 
and reverse primer, 1x final concentration SYBR Green I (Sigma-Aldrich,Spain), 10nM 
FAM (Bio-Rad, Spain) and 0.25 units of Taq DNA Polymerase. The amplification was 
performed in a HD 7900 thermal cycler thermal (Applied Biosystems, Spain) 
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programmed according to the following protocol: 1 minute at 95°C, followed by N 
repetitions of 30 seconds at 95°C, 30 seconds at 54°C and 30 seconds at 72°C.  
IV.IV.I. EXTRACTION OF PROLAMINS  
Each flour sample (Corn, Oats and Wheat) was weighed out in 100 mg aliquots. 
Flour samples were washed twice with 0.067 M phosphate buffer (in 0.4 M NaCl, pH = 
7.6) to remove the albumins and globulins and phosphate buffer was then added to flour 
aliquots to a final concentration of 100 mg/ml. The suspension was then vortexed for 2 
min at RT, followed by magnetic stirring for 15 min and spun down at 6000 g for 20 
min. Prolamins were extracted twice with 60% ethanol via addition of 1 ml of extractant 
to the flour pellets. The suspension was then vortexed vigorously at room temperature 
over a period of 30 min and spun down at 6000 g for 20 min.  
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IV.V | RESULTS AND DISCUSSION 
IV.V.I. SELEX AGAINST WHOLE GLIADIN 
A SELEX process can be described as the repetition of two different steps: 
partitioning and amplification. Partitioning is the core of the whole process: here the 
pool of nucleic acid is selected according to its binding to target and thus it is crucial to 
separate the bound sequences from the unbound ones. Generally, such separation occurs 
by using two different phases: a solid phase where the target-candidate aptamer is 
retained and a liquid phase where the unbound sequence is contained to be easily eluted 
and discharged. As gliadin is highly hydrophobic in nature, microtiter plates were used 
as the solid phase to immobilize the target: gliadins assume a well-ordered orientation 
when adsorbed onto a hydrophobic surface 13, preferable to the random orientation 
otherwise assumed, e.g. when covalently attached to a solid support.  
In the selection method used, the DNA pool was added to each wells of gliadin 
immobilized microtiter plate. The starting pool consisted of 500 pmol of a PAGE 
purified ssDNA pool- with an estimated complexity of 1014 different molecules-. In 
each selection round prior to incubation with the target, the pool underwent heating 
followed by rapid cooling, to unfold any pre-existing structures, formed due to intra- 
and inter- molecular pairing. The pool was diluted in the selection buffer with the tRNA 
and the BSA blocking agents and incubated with the immobilized gliadin for 30 
minutes at room temperature. After which the unbound sequences were removed in the 
supernatant, and following multiple washing steps, the sequences bound to the 
immobilized gliadin were eluted in 95°C hot water and amplified. In order to increase 
the stringency of the selection, the washing conditions became more extensive round by 
round: starting with three washings in binding buffer and ended by washing the plate 
twenty-four times in the binding buffer plus four additional times in milliQ water, to 
reduce weakly or unspecifically bound sequences14. Following its elution, the selected 
pool was amplified using PCR. While in the first cycle 18 cycles of amplification were 
used, in the following rounds the number of cycles was experimentally titrated, and as 
the process advanced the concentration of eluted DNA increased until only 9 
amplification cycles were required in the eighth round. To titrate the number of 
amplification cycles pilot PCR was performed, were a small aliquot of the eluted pool 
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was amplified in a range of 5 to 20 PCR cycles in order to decide the desired conditions 
of amplification to maintain the same amount of DNA for each cycle of SELEX. 
Following the final PCR, the resulting dsDNA pool was divided into two aliquots, one 
used in the subsequent round of selection, following generation of single stranded DNA 
and the other stored for the evolutionary studies. After eight SELEX rounds, the binding 
proprieties of the DNA pools from each round were evaluated using Surface Plasmon 
Resonance (SPR). Gliadin, anti-gliadin polyclonal antibody and streptavidin were each 
immobilized on different channels of a BIAcore CM5 chip, which consists of a four 
channels chip with a carboxy-methylated dextran modified gold surface. A reference 
channel containing only ethanolamine, used as blocking agent, was also prepared. The 
DNA pool from the last five selection rounds was amplified and 100nM ssDNA of each 
round was purified and injected into the four channels of the CM5 chip. The signals for 
all the three unspecific channels were similar and lower than the specific signal in 
gliadin channel, which was observed to increase after each round of SELEX (Fig 1).  
Once evolution had been established, the last round was cloned and sequenced. In 
the enriched library a small family of three members from 25 total sequences obtained 
was identified and referred to as G3, characterized by a high homology of the members 
(Fig.2).  
IV.V.II. DEVELOPMENT OF THE APTAPCR ASSAY 
The sequences obtained were tested for their ability to bind to gliadin adsorbed over 
a plate surface. Three different concentration of gliadin were immobilized on the 
microtiter plate. Subsequently 500nM of candidate aptamers were incubated for 30 
minutes. Following three subsequent washings, the bound DNA was heat-eluted and 
used as a template for the qPCR reaction. 
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Figure IV-1 EVALUATION OF THE BINDING PROPERTIES OF THE SSDNA POOLS AFTER EACH ROUND OF SELEX. RU 
reached at the plateau of the association curve for all different channels of the Biacore CM5 chip with DNA isolated 
from various rounds of SELEX (from the third to the eighth) using channels coated with whole gliadin, anti-gliadin 
Polyclonal IgG and streptavidin. Reference and buffer responses were subtracted. 
 
Figure IV-2 ALIGNMENT OF THE G3 SEQUENCES, PERFORMED USING TCOFFEE. 
The sequence G33 belonging to the family G3, was observed to be the best ligand, 
and was also observed to be able to discriminate gliadin from BSA and anti-gliadin IgG 
(Fig.3a and b). 





 BAD AVG GOOD
*
73g1   :  97
33g1   :  98
31g    :  97
cons   :  98
73g1   -AACTACTAACTAGGTAAGATCACGCCAGCACTAAACGACGTAGTT-TCCA
33g1   AAACTACTAACTAGGTAAGATCACG-CAGCACTAAACGACGTAGTT-GCCA
31g    AAACTACTAACTAGGTAAGATCACG-CAGCACTAAACGACGTAGTTGGCCA
cons    ************************ ********************  ***
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Figure IV-3 Candidates evaluation using aptaPCR. (A) ∆Ct-values determined using four different candidates 
incubated with three different concentration of gliadin, from 5 to 0 µg/mL.(B) ∆Ct values determined using 5µg/mL 
of BSA, antiglaiding polyclonal antibody (IgG) and Glaidin incubated with G33. 
With the aim of optimizing the assay, the concentration of the G33 was titrated 
(Supplementary Figure 2) and subsequently a competition assay was developed. 
Following the immobilization of 10µg/mL gliadin, the plate was blocked with 0.1% w/v 
of BSA, then thoroughly washed, followed by addiction of tRNA to minimize the 
unspecific adsorption of G33. Meanwhile, off plate 100nM G33 was incubated with 
different concentrations of gliadin (50 to 0 µg/mL) in the selection buffer and then 
added to each wells of the microtiter plate, where the gliadin in solution competes with 
the gliadin adsorbed on the plate for the binding of the aptamer. Finally the plate was 
washed and the eluted aptamer used as a template in qPCR. The limit of detection 
achieved was ≈ 100 ng/mL (Fig.4.A). As can be seen in figure 4B using either BSA or 
the albumin/globulin fraction extracted from the wheat flour or the prolamins extracted 
from corn and oats flours no cross-rectivity was observed as a solution of 30µg/mL of 
these proteins did not compete with the immobilized gliadin for the aptamer (Fig.4.B), 
highlighting the specificity of the selected G33 aptamer. 
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Figure IV-4 Gliadin detection through competitive assay. A) Determination of the Limit of the detection (LoD) 
indicated by the red dot. B) Ct value determined using 30 µg/mL of different proteins. The red line indicates the 
Limit of Detection calculated from two independent experiments. 
IV.VI | CONCLUSIONS 
Herein, we described the selection of an aptamer against food allergen gliadin - one 
of the first examples of an aptamer selected against a food allergen. Gliadin represents a 
particularly challenging target for aptamer selection due to its highly hydrophobic 
nature. However, this hydrophobic nature was exploited for its immobilization and a 
highly specific apatmer was successfully selected. The selected aptamer was applied to 
the detection of gliadin. Using aptaPCR, where the reporter aptamer was amplified 
using real time PCR, a detection limit of as low as 100ng/mL was achieved, and the 
aptamer showed negligible cross-reactivity to potential interferents.  This is the first 
example of the use of aptamer for food safety in the apta-PCR methodology and further 
demonstrates the wide potential use of the approach in diverse areas such as clinical 
diagnostics, food quality control and environmental monitoring 
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IV.IX | SUPPLEMENTARY INFORMATION 
1. Sequences obtained from the sequencing 
 
Figure IV-5 Supplementary Figure 1. SEQUENCES OBTAINED FROM THE SEQUENCING OF THE EIGHTH ROUND OF SELEX, 
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2. Tritation of the G33 aptamer to be used in the competition assay 
 
Figure IV-6 Supplementary Figure 2. TITRATION OF THE .G33 APTAMER TO BE USED IN THE COMPETITION ASSAY. To 
find the experimental conditions to be used in the competitive assay, different concentration of gliadins (from 0 to 
100µg/mL) where immobilized on a microtiter plate and incubated with different concentrations of G33 aptamer.  
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Chapter V | CONCLUSIONS AND FUTURE WORK  
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The thesis introduces and characterizes a novel ultrasensitive detection approach 
referred to as aptaPCR. The assay relies on the use of nucleic acid aptamers as 
combined binding reporter elements, a solution that combines the specificity of a 
generic aptamer with the sensitivity of nucleic acid amplification avoiding the need for 
any kind of labelling. 
In contrast to previously reported methods, the aptaPCR does not rely on the use of 
nucleases or ligases1-6 enzyme, facilitating a generally applicable assay for any aptamer-
target complex since there are no limitations imposed by the activity of an enzyme 
different from the polymerase. Likewise, the aptaPCR does not required the use of 
sophisticated equipment such as the capillary electrophoresis) 7. Our work can be 
considered as a crucial improvement of the work developed by of Fisher et al.8, as we 
merge the detection and the amplification propriety of a generic aptamer in a technique 
that can be applied to any type of ELISA format. In this thesis we used two different 
thrombin binding aptamers and their cognate target in a sandwich-type assay, where one 
aptamer was immobilized on a surface and captured the protein of interest which then 
exposed to a second aptamer (the reporter). Following elution of this reporter, it acts as 
a template for subsequent amplification, facilitating its detection. It was demonstrated 
that the novel approach yields a massive improvement (20000-fold enhancement) in 
terms of limit of detection, when compared with methods previously described. The 
reported approach is applicable to all aptamers, independent of whether there exists 
double aptamers against the target, and the technique can thus be applied to the 
detection of very low concentrations of target analytes, which is garnering ever-
increasing importance in pre-emptive medicine and the early diagnosis of disease, as 
well as in food analysis control and environmental monitoring.  
Subsequently it was demonstrated that the developed approach could be 
successfully used for the detection of ultralow levels of proteins that are not inactivated 
or disrupted by the detection itself. Further improving on the assay previously 
developed, we demonstrated a novel application of caged aptamers as light-dependent 
templates for aptaPCR. Caged aptamers enable the disruption of analyte and aptamer 
complexes by irradiation with light (λ = 365 nm). This approach, compared to other 
reported aptaPCR assays, is a far more straightforward qPCR format, where no 
purification of the eluted aptamer is necessary and, thus, there is minimal loss of the 
reporter aptamer prior to quantification. Moreover, the elution by irradiation maintains 
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the analyte in its native state allowing it to be used for further testing. This has been 
exemplified in our study, where we investigated the functional integrity of thrombin 
before and after irradiation and elution of the aptamer for qPCR amplification. The 
approach introduced in this study can be applied to virtually every aptamer-target pair 
and, thus, it can be generalized to measure a diverse set of clinically relevant proteins 
and biomarkers. This approach may be also applicable to analyze proteomes with 
spatiotemporal resolution. 
 Finally, further extending the applicability of the aptaPCR established, the detection 
of the food allergen gluten was described. The first DNA anti-Gliadin aptamer so far 
described was selected and subsequently used in the detection of its cognate target 
through the aptaPCR approach. The aptamer selection was achieved using the 
Systematic Evolution of Ligand by EXponential enrichment (SELEX) process, which 
permitted the screening of a vast library of synthetic single stranded DNA library (1013 
members) through the repetition of different rounds of amplification and selection. 
After eight rounds of selection the enriched library was cloned and sequenced 
identifying and a highly conserved sequence. This sequence was characterized for its 
specificity and used to set up a competitive aptaPCR assay. Here different 
concentrations of the analytes free in solution compete for the selected aptamer with a 
standard concentration of the target adsorbed on a microtiter plate. Upon its elution 
from the plate, the aptamer served as a template for the subsequent qPCR, permitting to 
achieve a limit of detection of hundreds ng/mL of analyte. 
Overall, this thesis has contributed significantly to the development of assays using 
aptamer as a recognition element (apta-assay). We pioneered the development of a 
novel assay format, termed aptaPCR, which exploits the unique biochemical and 
chemical proprieties of the aptamers. Our assay mimics the commonly used 
immunoassay and can be widely used with any aptamer – target combination.  
To extend the application of the developed aptaPCR, it’s robustness and wide 
applicability should be addressed by application to the detection of thrombin in real 
samples, and extending to new aptamer-target combinations including other food 
allergens and clinical biomarkers. Furthermore, the combination of aptaPCR with caged 
aptamers could lead to a novel ultrasensitive detection assay for the capture of 
disseminated whole cancer cells, whilst keeping them intact for further analysis.  
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Concluding this dissertation, sometimes before the start of this work, in 2007 
C.Stein, PhD and MD at Albert Einstein College of Medicine in New York, talking 
about aptamers declared: “Aptamers ... are going to find their own niche, which I think 
could be very substantial.”9. I belive that this thesis demonstrated that the aptaPCR 
assay will find such a niche for aptamers in analysis. 
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